地址:武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301
电话:15172469628
传真:18771997407
邮箱:sales@amyjet.com

IBI Scientific是一家综合性的生物实验用品生产商,主要产品包括Belly Dancer Shaker、IBI electrophoresis、IBI Molecular Biology reagents和其他生物研究用品。
IBI Scientific is an ISO 9001:2015 Certified manufacturer of Life Science Research Products including laboratory equipment such as the Belly Dancer Shaker, IBI electrophoresis products, IBI Molecular Biology reagents, and many other high quality Life Science Research products.
IBI Scientific的主要产品包括:
Animal Holders
Beta Protection & Acrylic Lab Products
Electrophoresis
Lab Equipment
Microbiology Products
PCR Reagents
Purification Products
Reagents
Recombinant Proteins
UltraPure Water Products
<更多详情请联系
艾美捷科技有限公司
全国服务热线:400-6800-868
邮箱:sales@amyjet.com
网站:www.amyjet.com
" data-original="http://pharna.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="IBI Scientific"> IBI Scientific
艾美捷科技代理Berry & Associates全系列修饰核苷酸等
美国 Berry & Associates 公司成立于1989年,提供近200种亚磷酰胺和核苷酸合成用固相交联单体,以及数百种核苷、核苷酸、糖类、荧光标记物、淬灭剂和杂环化合物。
Founded in 1989 with roots in the nucleoside field, Berry & Associates soon moved into the chemistry of nucleic acids, resulting in a current portfolio of nearly 200 phosphoramidites and solid phase-linked monomers for oligonucleotide synthesis as well as hundreds of nucleosides, nucleotides, carbohydrates, spacers, fluorescent markers, quenchers, and heterocycles - all proudly made at our facility just outside of Ann Arbor, Michigan. Although our company is small, the credentials of our highly trained staff of chemists include over 400 publications and 80 patents in synthetic organic and medicinal chemistry. High quality chemicals, timeliness, and personalized service are the hallmarks of Berry & Associates.







Berry & Associates的主要产品包括:
| 产品名称 | 产品编号 | 纯度 | 规格 |
| 2',3'-Dideoxyadenosine | PR 3495 | ≥95% | 25 mg; 100 mg |
| 2'-3'-Dideoxyguanosine | PR 3505 | ≥95% | 25 mg; 100 mg |
| 2',3'-Dideoxyinosine | PR 3727 | ≥97% | 100 mg; 1 g |
| 3'-Deoxythymidine | PY 7277 | ≥95% | 50 mg; 100 mg |
| 2',3'-Dideoxyuridine | PY 7278 | ≥97% | 100 mg; 500 mg |
| 2',3'-Didehydro-2',3'-dideoxyuridine | PY 7279 | ≥97% | 25 mg; 100 mg |
| 2',3'-Dideoxycytidine | PY 7325 | ≥95% | 50 mg; 100 mg |
| 2-Aminoadenosine (2,6-Diaminopurine riboside) | PR 3030 | ≥97% | 2 g; 10 g |
| 2-Amino-2'-deoxyadenosine | PR 3060 | ≥97% | 1 g; 5 g |
| 2-Amino-5'-O-(dimethoxytrityl)-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-deoxyadenosine | PR 3080 | ≥95% | 100 mg; 1 g |
| 2-Amino-5'-O-(dimethoxytrityl)-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-O-methyladenosine | PR 3090 | ≥97% | 250 mg; 1 g |
| 2-Amino-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-O-methyladenosine | PR 3110 | ≥95% | 250 mg; 1 g |
| 2-Amino-N2-isobutyryl-2'-deoxyadenosine | PR 3130 | ≥95% | 100 mg; 1 g |
| 2-Amino-N2-O-methyladenosine | PR 3150 | ≥97% | 1 g; 10 g |
| 2-(Dimethylaminomethylidene)amino-6-methoxylamino-9-(β-D-2-deoxyribofuranosyl)purine | PR 3670 | ≥95% | 100 mg; 1 g |
| 2-Amino-9-(β-D-2'-deoxyribfuranosyl)purine | PR 3070 | ≥97% | 25 mg; 100 mg |
| 2-Amino-9-(2-O-methyl-β-D-ribofuranosyl)purine | PR 3160 | ≥97% | 100 mg; 250 mg |
| 2-Amino-9-(β-D-ribofuranosy)purine Hemihydrate | PR 3180 | ≥97% | 25 mg; 100 mg |
| 2-(Dimethylaminomethylidene)amino-9-(β-D-2-deoxyribofuranosyl)purine | PR 3680 | ≥97% | 100 mg; 1 g |
| 6-N-Acyl-6-N-methyl-2'-deoxyadenosine | PR 3006 | ≥95% | 25 mg; 100 mg |
| 8-Amino-2'-deoxyadenosine | PR 3115 | ≥97% | 10 mg; 100 mg |
| N6-(6-Aminohexyl)-2'-deoxyadenosine | PR 3120 | ≥90% | 100 mg; 1 g |
| 8-Azido-2'-deoxyadenosine | PR 3125 | ≥97% | 10 mg; 100 mg |
| N6-Benzoyl-8-benzyloxy-2'-deoxyadenosine | PR 3230 | ≥95% | 50 mg; 250 mg |
| N6-Benzoyl-5'-O-(dimethoxytrityl)-8-oxo-2'-deoxyadenosine | PR 3260 | ≥95% | 100 mg; 1 g |
| N6-Benzoyl-8-oxo-2'-deoxyadenosine | PR 3270 | ≥97% | 100 mg; 1 g |
| 8-Benzyloxy-2'-deoxyadenosine | PR 3280 | ≥97% | 100 mg; 1 g |
| 8-Bromo-2'-deoxyadenosine | PR 3290 | ≥90% | 2 g; 10 g |
| 8-Bromo-N6-(dimethylaminomethylidene)-2'-deoxyadenosine | PR 3320 | ≥95% | 100 mg; 1 g |
| 8-Bromo-5'-O-(dimethoxytrityl)-N6-(dimethylaminomethylidene)-2'-deoxyadenosine | PR 3340 | ≥97% | 0g (discontinued); |
| 2'-Deoxyadenosine Monohydrate | PR 3445 | ≥97% | 25 g; 100 g |
| 2',3'-Dideoxyadenosine | PR 3495 | ≥95% | 25 mg; 100 mg |
| 2-Fluoro-2'-deoxyadenosine | PR 3496 | ≥97% | 25 mg; 1 g |
| 8-Oxo-2'-deoxyadenosine | PR 3705 | ≥95% | 25 mg; 250 mg |
| N6-Methyl-2'-deoxyadenosine | PR 3740 | ≥97% | 100 mg; 1 g |
| 4-Chloro-1-(2-deoxy-β-D-ribofuranosyl)-7-methyl-1H-imidazo[4,5-c]pyridine | PRA 10012 | ≥95% | 10 mg; 50 mg |
| 3-Deaza-3-methyl-2'-deoxyadenosine | PRA 10013 | ≥97% | 10 mg; 25 mg |
| 5'-O-Dimethoxytrityl-N6-(N,N-dimethylaminomethylene)-8-aza-7-deaza-2'-deoxyadenosine | PRA 10019 | ≥97% | 500 mg; 1 g |
| 7-(3-Nitrophenyl)-7-deaza-2'-deoxyadenosine | PRA 10032 | ≥95% | 10 mg; 50 mg |
| 5-Iodo-2'-deoxytubercidin | PRA 10036 | ≥95% | 10 mg; 50 mg |
| 8-Allyloxy-2'-deoxyguanosine | PR 3010 | ≥90% | 0Discontinued; |
| 8-Allyloxy-N2-(dimethylaminomethylidene)-2'-deoxyguanosine | PR 3015 | ≥90% | 1 g; 10 g |
| 8-Allyloxy-N2-isobutyryl-2'-deoxyguanosine | PR 3020 | ≥90% | 1 g; 10 g |
| 5'-Azido-5'-deoxyguanosine | PR 3225 | ≥90% | 5 mg; 10 mg |
| 8-Benzyloxy-N2-isobutyryl-2'-deoxyguanosine | PR 3285 | ≥90% | 1 g; 10 g |
| 8-Bromo-2'-deoxyguanosine | PR 3300 | ≥90% | 1 g; 5 g |
| 8-Bromo-5'-O-(dimethyoxytrityl)-N2-(dimethyl-aminomethylidene)-2'-deoxyguanosine | PR 3310 | ≥97% | 500 mg; 1 g |
| 8-Bromo-N2-(dimethylaminomethylidene)-2'-deoxyguanosine | PR 3330 | ≥90% | 250 mg; 1 g |
| 5'-O-Dimethoxytrityl-N2-(dimethylaminomethylidene)-8-ethenyl-2'-deoxyguanosine | PR 3335 | ≥95% | 100 mg; 1 g |
| 2'-Deoxyguanosine monohydrate | PR 3452 | ≥97% | 10 g; 100 g |
| α-2'-Deoxyguanosine | PR 3455 | ≥97% | 10 mg; 100 mg |
| 2'-Deoxyisoguanosine | PR 3465 | ≥97% | 10 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-N2-ethyl-2'-deoxyguanosine | PR 3600 | ≥97% | 100 mg; 1 g |
| 3',5'-Di-O-acetyl-2'-deoxyguanosine | PR 3605 | ≥97% | 500 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-8-Oxo-N2-isobutyryl-2'-deoxyguanosine | PR 3610 | ≥97% | 100 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-N2-methyl-2'-deoxy-guanosine | PR 3630 | ≥97% | 100 mg; 1 g |
| N2-Ethyl-2'-deoxyguanosine | PR 3700 | ≥95% | 25 mg; 100 mg |
| 5'-O-Dimethoxytrityl-N2-(trifluoroacetamido)hexyl-2'-deoxyguanosine | PR 3701 | ≥95% | 25 mg; 100 mg |
| 8-Oxo-2'-deoxyguanosine | PR 3710 | ≥97% | 25 mg; 250 mg |
| 8-Oxo-N2-isobutyryl-2'-deoxyguanosine | PR 3720 | ≥90% | 100 mg; 1 g |
| N2-Isobutyl-2'-deoxyguanosine | PR 3745 | ≥97% | 10 mg; 100 mg |
| N1-Methyl-2'-deoxyguanosine | PR 3748 | ≥97% | 25 mg; 1 g |
| N2-Methyl-2'-deoxyguanosine | PR 3750 | ≥97% | 25 mg; 100 mg |
| O6-Methyl-2'-deoxyguanosine | PR 3755 | ≥90% | 5 mg; 25 mg |
| 6-Thio-2'-deoxyguanosine | PR 3845 | ≥97% | 10 mg; 100 mg |
| 7-Methyl-7-deaza-2'deoxyguanosine | PRA 10042 | ≥97% | 10 mg; 50 mg |
| 2'-Deoxypseudoguanosine | PRA 10103 | ≥97% | 10 mg; 50 mg |
| 2'-Deoxypseudoisoguanosine | PRA 10104 | ≥97% | 10 mg; 100 mg |
| 8-Aza-7-deaza-2'-deoxyguanosine | PRA 10170 | ≥95% | 10 mg; 100 mg |
| 6-Amino-2-(2-deoxy-β-D-ribofuranosyl)-2,5-dihydro-4H-pyrazolo-[3,4-d]-pyrimidin-4-one | PRA 10175 | ≥95% | 10 mg; 100 mg |
| 2-Amino-5'-O-(dimethoxytrityl)-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-O-methyladenosine | PR 3090 | ≥97% | 250 mg; 1 g |
| 2-Amino-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-O-methyladenosine | PR 3110 | ≥95% | 250 mg; 1 g |
| 2-Amino-N2-O-methyladenosine | PR 3150 | ≥97% | 1 g; 10 g |
| 2',3'-Di-O-methyladenosine | PR 3540 | ≥97% | 100 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-2'-O-methylinosine | PR 3640 | ≥97% | 1 g; |
| N6-Methyl-2'-O-Methyladenosine | PR 3733 | ≥97% | 50 mg; 100 mg |
| 2'-O-Methyladenosine | PR 3734 | ≥97% | 1 g; |
| 2'-O-Methylguanosine | PR 3760 | ≥97% | 1 g; 10 g |
| 2'-O-Methylinosine | PR 3770 | ≥97% | 500 mg; 1 g |
| N4-Acetyl-5'-O-(dimethoxytrityl)-5-methyl-2'-O-methylcytidine | PY 7010 | ≥95% | 0 g DISCONTINUED; |
| N4-Acetyl-5'-methyl-2'-O-methylcytidine | PY 7020 | ≥97% | 0 g DISCONTINUED; |
| N4-Benzoyl-5'-O-(dimethoxytrityl)-5-methyl-2'-O-methylcytidine | PY 7100 | ≥95% | 100 mg; 1 g |
| N4-Benzoyl-2'-O-methylcytidine | PY 7110 | ≥97% | 500 mg; 1 g |
| 3',5'-Di-O-acetyl-5-fluoro-O4-(2,4,6-trimethylphenyl)-2'-O-methyluridine | PY 7290 | ≥95% | 500 mg; 1 g |
| 3',5'-Di-O-acetyl-5-fluoro-2'-O-methyluridine | PY 7300 | ≥97% | 50 mg; 250 mg |
| 3',5'-Di-O-benzoyl-5-fluoro-2'-O-methyluridine | PY 7320 | ≥97% | 500 mg; 1 g |
| N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-iodo-2'-O-methylcytidine | PY 7350 | ≥97% | 0 DISCONTINUED; |
| N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-O-methylcytidine | PY 7360 | ≥97% | 0 DISCONTINUED; |
| N4-(Diisobutylaminomethylidene)-5-iodo-2'-O-methylcytidine | PY 7370 | ≥97% | 0 DISCONTINUED; |
| 5'-O-(Dimethoxytrityl)-5-fluoro-2'-O-methyluridine | PY 7420 | ≥95% | 100 mg; 500 mg |
| 5'-O-(Dimethoxytrityl)-5-iodo-2'-O-methyluridine | PY 7460 | ≥97% | 50 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-5-methyl-2'-O-methyluridine | PY 7470 | ≥97% | 100 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-2'-O-methyluridine | PY 7480 | ≥97% | 500 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-O-methyluridine | PY 7500 | ≥95% | 25 mg; 100 mg |
| 5-Fluoro-2'-O-methyluridine | PY 7570 | ≥97% | 50 mg; 100 mg |
| 5-Fluoro-2'-O-methyl-4-thiouridine | PY 7575 | ≥97% | 10 mg; 100 mg |
| 5-Fluoro-2'-O-methyl-4-(methylithio)uridine | PY 7577 | ≥97% | 10 mg; 100 mg |
| 5-Iodo-2'-O-methylcytidine | PY 7620 | ≥90% | 20 mg; 100 mg |
| 5-Iodo-2'-O-methyluridine | PY 7630 | ≥97% | 100 mg; 1 g |
| 2'-O-Methylcytidine | PY 7636 | ≥97% | 1 g; 5 g |
| 5-Methyl-2'-O-methylcytidine | PY 7640 | ≥97% | 100 mg; 500 mg |
| 5-Methyl-2'-O-methyluridine | PY 7650 | ≥97% | 100 mg; 1 g |
| 5-(1-Propynyl)-2'-O-methylcytidine | PY 7660 | ≥95% | 10 mg; 50 mg |
| 5-(1-Propynyl)-2'-O-methyluridine | PY 7670 | ≥97% | 10 mg; 25 mg |
| 2'-O-Methyluridine | PY 7690 | ≥97% | 5 g; |
| 5'-O-Acetyl-3'-azido-N2-palmitoyl-2',3'-dideoxy-guanosine | PR 3000 | ≥97% | 25 mg; 250 mg |
| 3'-Azido-N6-benzoyl-2',3'-dideoxyadenosine | PR 3200 | ≥90% | 50 mg; 250 mg |
| 3'-Azido-2',3'-dideoxyadenosine | PR 3210 | ≥97% | 10 mg; 25 mg |
| 3'-Azido-2',3'-dideoxyguanosine | PR 3220 | ≥97% | 10 mg; 25 mg |
| 3'-Azido-3'-deoxythymidine (AZT) | PY 7065 | ≥97% | 500 mg; 1 g |
| 3'-Azido-3'-deoxy-5'-O-methylthymidine | PY 7075 | ≥97% | 0 g DISCONTINUED; |
| 3'-Azido-2',3'-dideoxy-5-bromouridine | PY 7286 | ≥97% | 10 mg; 50 mg |
| N6-Benzoyl-3'-deoxyadenosine | PR 3240 | ≥97% | 100 mg; 1 g |
| N6-Benzoyl-5'-O-(dimethoxytrityl)-3'-deoxyadenosine | PR 3250 | ≥97% | 100 mg; 1 g |
| 3'-Deoxyadenosine | PR 3430 | ≥97% | 10 mg; 100 mg |
| 3'-Deoxyguanosine | PR 3460 | ≥97% | 10 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-N2-(dimethylaminomethylidene)-3'-deoxyguanosine | PR 3590 | ≥97% | 100 mg; 1 g |
| N2-(Dimethylaminomethylidene)-3'-deoxyguanosine | PR 3690 | ≥97% | 20 mg; 100 mg |
| 2'-O-Acetyl-5'-O-benzoyl-5-methyl-3'-deoxyuridine | PY 7000 | ≥97% | 500 mg; 1 g |
| N4-Benzoyl-3'-deoxycytidine | PY 7080 | ≥97% | 20 mg; 100 mg |
| 3'-Deoxycytidine | PY 7220 | ≥97% | 20 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-5-methyl-3'-deoxyuridine | PY 7240 | ≥95% | 25 mg; 100 mg |
| 5-Methyl-3'-deoxyuridine | PY 7260 | ≥95% | 20 mg; 50 mg |
| 5'-O-(Dimethoxytrityl)-5,6-dihydro-2'-deoxyuridine | PY 7230 | ≥97% | 100 mg; |
| 5,6-Dihydro-2'-deoxyuridine | PY 7330 | ≥97% | 100 mg; |
| (5S)-5,6-Dihydrothymidine | PY 7340 | ≥97% | 20 mg; 100 mg |
| (5S)-5'-O-(Dimethoxytrityl)-5,6-dihydrothymidine | PY 7390 | ≥97% | 100 mg; |
| N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-O-methylcytidine | PY 7360 | ≥97% | 0 DISCONTINUED; |
| N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-deoxycytidine | PY 7400 | ≥97% | 100 mg; 500 mg |
| 5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-deoxyuridine | PY 7490 | ≥95% | 50 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-O-methyluridine | PY 7500 | ≥95% | 25 mg; 100 mg |
| 5-(1-Propynyl)-2'-O-methylcytidine | PY 7660 | ≥95% | 10 mg; 50 mg |
| 5-(1-Propynyl)-2'-O-methyluridine | PY 7670 | ≥97% | 10 mg; 25 mg |
| 5-(1-Propynyl)-2'-deoxycytidine | PY 7700 | ≥90% | 5 mg; 10 mg |
| 5-(1-Propynyl)-2'-deoxyuridine | PY 7710 | ≥97% | 100 mg; 1 g |
| 2-Amino-6-chloro-9-(β-D-2-deoxyribofuranosyl)purine | PR 3040 | ≥97% | 1 g; |
| 2-Amino-6-chloro-9-(3,5-di-(p-toluoyl)-β-D-2-deoxyribofuranosyl)purine | PR 3045 | ≥95% | 1 g; |
| 2-Amino-6-chloro-9-(β-D-ribofuranosyl)purine | PR 3050 | ≥95% | 5 g; 25 g |
| 6-Chloro-9-(β-D-2-deoxyribofuranosyl)purine | PR 3370 | ≥97% | 100 mg; 1 g |
| 6-Chloro-9-(3,5-O-di-(p-toluoyl)-β-D-2-deoxyribofuranosyl)purine | PR 3380 | ≥90% | 100 mg; 1 g |
| 6-Chloro-9-(5-O-dimethoxytrityl-β-D-2-deoxyribofuranosyl)purine | PR 3390 | ≥97% | 0 g; |
| 6-Chloro-9-(β-D-ribofuranosyl)purine | PR 3400 | ≥97% | 5 g; 10 g |
| Adenosine | PR 3005 | ≥97% | 100 g; 1 kg |
| 8-Methyladenosine | PR 3007 | ≥95% | 25 mg; 100 mg |
| Vidarabine | PR 3008 | ≥97% | 1 g; 5 g |
| 2-Aminoadenosine (2,6-Diaminopurine riboside) | PR 3030 | ≥97% | 2 g; 10 g |
| N1-Methyladenosine hydroiodide | PR 3032 | ≥95% | 100 mg; 1 g |
| 2-Methyladenosine | PR 3035 | ≥97% | 10 mg; 25 mg |
| 5'-Chloro-5'-deoxyadenosine | PR 3360 | ≥97% | 100 mg; 1 g |
| N6-Methyladenosine | PR 3732 | ≥97% | 100 mg; 1 g |
| N6-Methyl-2'-O-Methyladenosine | PR 3733 | ≥97% | 50 mg; 100 mg |
| 3-Deaza-3-methyl-2'-deoxyadenosine | PRA 10013 | ≥97% | 10 mg; 25 mg |
| 7-Deazaadenosine (tubercidin) | PRA 10035 | ≥97% | 10 mg; 100 mg |
| 5-Iodo-2'-deoxytubercidin | PRA 10036 | ≥95% | 10 mg; 50 mg |
| 2-Amino-4-chloro-7-(β-D-2-deoxyribofuranosyl)pyrrolo[2,3-d]pyrimidine | PRA 10000 | ≥97% | 100 mg; 1 g |
| 2-Amino-4-methoxy-7-(β-D-2-deoxyribofuranosyl)pyrrolo[2,3-d]pyrimidine | PRA 10005 | ≥97% | 500 mg; 1 g |
| 4-Chloro-1-(β-D-2-deoxyribofuranosyl)imidazo[4,5-C]pyridine | PRA 10006 | ≥90% | 25 mg; 100 mg |
| 8-Azaadenosine | PRA 10007 | ≥97% | 20 mg; |
| 8-Aza-7-deaza-2'-deoxyadenosine (4-Amino-1-(2-deoxyribofuranosyl)pyrazolo[3,4-d]-pyrimidine) | PRA 10008 | ≥95% | 10 mg; 100 mg |
| 4-Chloro-1-(3,5-di-O-toluoyl-2-deoxy-β-D-ribofuranosyl)pyrazolo[3,4-d]pyrimidine | PRA 10009 | ≥95% | 100 mg; 1 g |
| N6-Benzoyl-7-deaza-2'-deoxyadenosine | PRA 10010 | ≥97% | 100 mg; 1 g |
| Allopurinol riboside | PRA 10011 | ≥97% | 25 mg; 1 g |
| 5'-O-Dimethoxytrityl-N6-(N,N-dimethylaminomethylene)-8-aza-7-deaza-2'-deoxyadenosine | PRA 10019 | ≥97% | 500 mg; 1 g |
| N6-Benzoyl-5'-O-(dimethoxytrityl)-7-deaza-2'-deoxyadenosine | PRA 10020 | ≥97% | 100 mg; 1 g |
| 3-Deaza-2'-deoxyadenosine | PRA 10025 | ≥97% | 25 mg; 100 mg |
| 7-Deaza-2'-deoxyadenosine | PRA 10030 | ≥97% | 100 mg; 1 g |
| 7-Deazaadenosine (tubercidin) | PRA 10035 | ≥97% | 10 mg; 100 mg |
| 5-Iodo-2'-deoxytubercidin | PRA 10036 | ≥95% | 10 mg; 50 mg |
| 7-Deaza-2'-deoxyguanosine | PRA 10040 | ≥97% | 100 mg; 1 g |
| 7-Deazaguanosine | PRA 10045 | ≥97% | 10 mg; 100 mg |
| 7-Deaza-2'-deoxyxanthosine | PRA 10050 | ≥97% | 50 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-7-deaza-2'-deoxyxanthosine | PRA 10055 | ≥97% | 100 mg; 1 g |
| 1-(β-D-2-Deoxyribofuranosyl)-5-nitroindole | PRA 10060 | ≥97% | 100 mg; 1 g |
| 1-(β-D-2-Deoxyribofuranosyl)-4-methylindole | PRA 10070 | ≥97% | 0 g; |
| 1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-4-methylindole | PRA 10080 | ≥97% | 0 g; |
| 1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-5-nitroindole | PRA 10090 | ≥97% | 100 mg; 1 g |
| 5-Iodotubercidin | PRA 10095 | ≥90% | 5 mg; 25 mg |
| 5'-O-(Dimethoxytrityl)-N2-(dimethylaminomethylidene)-7-deaza-2'-deoxyguanosine | PRA 10100 | ≥97% | 100 mg; 1 g |
| N2-(Dimethylaminomethylidene)-7-deaza-2'-deoxyguanosine | PRA 10110 | ≥97% | 100 mg; 1 g |
| Sangivamycin | PRA 10140 | ≥97% | 10 mg; 25 mg |
| Toyocamycin | PRA 10150 | ≥97% | 10 mg; 100 mg |
| Triciribine | PRA 10160 | ≥97% | 10 mg; |
| Tricyclic Nucleoside Phosphate | PRA 10162 | ≥95% | 10 mg; |
| 8-Aza-7-deaza-2'-deoxyguanosine | PRA 10170 | ≥95% | 10 mg; 100 mg |
| 6-Amino-2-(2-deoxy-β-D-ribofuranosyl)-2,5-dihydro-4H-pyrazolo-[3,4-d]-pyrimidin-4-one | PRA 10175 | ≥95% | 10 mg; 100 mg |
| Formycin A | PYA 11001 | ≥97% | 10 mg; |
| Formycin B | PYA 11002 | ≥97% | 10 mg; |
| dNaM | FC 8110 | ≥97% | 25 mg; 100 mg |
| 9-Deaza-2'-deoxyguanosine | PRA 10120 | ≥97% | 10 mg; 100 mg |
| 9-Deazaguanosine | PRA 10130 | ≥97% | 10 mg; 100 mg |
| 2-Chloro-6-(β-D-2-deoxyribofuranosyl)-3,5-diaminopyrazine | PYA 11000 | ≥97% | 10 mg; 25 mg |
| Formycin A | PYA 11001 | ≥97% | 10 mg; |
| Formycin B | PYA 11002 | ≥97% | 10 mg; |
| Pyrazofurin | PYA 11004 | ≥97% | 10 mg; |
| 2'-Deoxypseudoisocytidine | PYA 11005 | ≥97% | 10 mg; 100 mg |
| 2'-Deoxypseudouridine | PYA 11010 | Purity: ≥97% | 25 mg; |
| 5'-O-(Dimethoxytrityl)-N-(dimethylamino) methylidene-2'-deoxypseudoisocytidine | PYA 11035 | Purity: ≥97% | 50 mg; 100 mg |
| 1,3-Dimethyl-2'-deoxypseudouridine | PYA 11040 | ≥97% | 10 mg; 100 mg |
| 1,3-Dimethylpseudouridine | PYA 11050 | ≥97% | 10 mg; 50 mg |
| N1-Methylpseudouridine | PYA 11052 | ≥95% | 10 mg; 50 mg |
| N3-Methylpseudouridine | PYA 11054 | ≥97% | 10 mg; 25 mg |
| Showdomycin | PYA 11056 | ≥97% | 10 mg; |
| Pseudoisocytidine hydrochloride | PYA 11060 | ≥97% | 10 mg; 100 mg |
| Pseudothymidine | PYA 11070 | ≥97% | 10 mg; 100 mg |
| Pseudouridine | PYA 11080 | ≥97% | 10 mg; 50 mg |
| 3'-O-(t-Butyldimethylsilyl)-5'-oxo-2'-deoxy-8,5'-cycloadenosine | PR 3350 | ≥97% | 10 mg; |
| (5'S)-8,5'-Cycloadenosine | PR 3410 | ≥97% | 10 mg; 100 mg |
| (5'S)-2'-Deoxy-8,5'-cycloadenosine | PR 3420 | ≥97% | 10 mg; |
| 5'-Deoxy-8,5'-cycloadenosine | PR 3440 | ≥97% | 10 mg; 100 mg |
| 2',5'-Dideoxy-8,5'-cycloadenosine | PR 3500 | ≥97% | 10 mg; |
| 2',3'-O-Isopropylidene-5'-oxo-8,5'-cycloadenosine | PR 3730 | ≥97% | 10 mg; 100 mg |
| 5'-Oxo-8,5'-cycloadenosine | PR 3800 | ≥97% | 10 mg; 100 mg |
| 5'-Oxo-2'-deoxy-8,5'-cycloadenosine | PR 3810 | ≥97% | 10 mg; |
| N4-Acetyl-5'-O-(dimethoxytrityl)-5-methyl-2'-O-methylcytidine | PY 7010 | ≥95% | 0 g DISCONTINUED; |
| N4-Acetyl-5'-methyl-2'-O-methylcytidine | PY 7020 | ≥97% | 0 g DISCONTINUED; |
| N4-Benzoyl-5-(furan-2-yl)-2'-deoxycytidine | PY 7054 | ≥97% | 25 mg; 100 mg |
| N4-Benzoyl-3'-deoxycytidine | PY 7080 | ≥97% | 20 mg; 100 mg |
| N4-Benzoyl-5'-O-(dimethoxytrityl)-5-methyl-2'-O-methylcytidine | PY 7100 | ≥95% | 100 mg; 1 g |
| N4-Benzoyl-2'-O-methylcytidine | PY 7110 | ≥97% | 500 mg; 1 g |
| 5-Bromo-2'-deoxycytidine | PY 7115 | ≥97% | 1 g; 10 g |
| Cytidine | PY 7215 | ≥97% | 50 g; 500 g |
| 2'-Deoxycytidine | PY 7216 | ≥97% | 10 g; 50 g |
| 2'-Deoxycytidine Hydrochloride | PY 7217 | ≥97% | 5 g; 50 g |
| 5'-Azido-2',5'-dideoxycytidine | PY 7219 | ≥97% | 25 mg; 100 mg |
| 3'-Deoxycytidine | PY 7220 | ≥97% | 20 mg; 100 mg |
| N4-Ethyl-2'-deoxycytidine | PY 7245 | ≥97% | 100 mg; 250 mg |
| 5-Methyl-2'-deoxyisocytidine | PY 7255 | ≥95% | 500 mg; 1 g |
| 6-(β-D-2-Deoxyribofuranosyl)-3,4-dihydro-8H-pyrimido-[4,5-c][1,2]oxazin-7-one | PY 7270 | ≥97% | 20 mg; 50 mg |
| 2',3'-Dideoxycytidine | PY 7325 | ≥95% | 50 mg; 100 mg |
| N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-iodo-2'-O-methylcytidine | PY 7350 | ≥97% | 0 DISCONTINUED; |
| N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-O-methylcytidine | PY 7360 | ≥97% | 0 DISCONTINUED; |
| N4-(Diisobutylaminomethylidene)-5-iodo-2'-O-methylcytidine | PY 7370 | ≥97% | 0 DISCONTINUED; |
| 6-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-3,4-dihydro-8H-pyrimido-[4,5-c][1,2]oxazin-7-one | PY 7380 | ≥97% | 50 mg; |
| N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-deoxycytidine | PY 7400 | ≥97% | 100 mg; 500 mg |
| 5-O-(Dimethoxytrityl)-N4-dimethylaminomethylidene-5-iodo-2'-deoxycytidine | PY 7410 | ≥97% | 100 mg; |
| 6-(3,5-Di-O-(p-toluoyl)-β-D-2-deoxyribofuranosyl)-3,4-dihydro-8H-pyrimido[4,5-c][1,2]oxazin-7-one | PY 7540 | ≥95% | 250 mg; 500 mg |
| Cytidin-5-yl-methanesulfonate sodium salt hydrate | PY 7586 | ≥95% | 50 mg; 100 mg |
| 5-[(2-Cyanoethoxy)methyl]-2'-deoxycytidine | PY 7587 | ≥97% | 10 mg; 50 mg |
| 5-Hydroxymethyl-2'-deoxycytidine | PY 7588 | ≥97% | 50 mg; 100 mg |
| 5-Formyl-2'-deoxycytidine | PY 7589 | ≥97% | 5 mg; 10 mg |
| 5-Carboethoxy-2'-deoxycytidine | PY 7592 | ≥95% | 25 mg; 100 mg |
| 2'-Deoxycytidine-5-carboxylic acid, sodium salt | PY 7593 | ≥95% | 25 mg; 100 mg |
| 5-Hydroxy-2'-deoxycytidine | PY 7595 | ≥95% | 25 mg; 250 mg |
| 5-Hydroxymethylcytidine | PY 7596 | ≥97% | 50 mg; 100 mg |
| Cytidine-5-carboxylic acid, sodium salt | PY 7598 | ≥97% | 10 mg; 50 mg |
| 5-Formylcytidine | PY 7599 | ≥97% | 5 mg; 10 mg |
| 5-Iodo-2'-deoxycytidine | PY 7607 | ≥97% | 2 g; 10 g |
| 5-Iodocytidine | PY 7609 | ≥97% | 5 g; |
| 5-Iodo-2'-O-methylcytidine | PY 7620 | ≥90% | 20 mg; 100 mg |
| 5-Methyl-2'-deoxycytidine Hydrochloride | PY 7635 | ≥97% | 0.25 g; 1 g |
| 2'-O-Methylcytidine | PY 7636 | ≥97% | 1 g; 5 g |
| 5-Methylcytidine | PY 7637 | ≥97% | 1 g; 5 g |
| N4-Methylcytidine | PY 7638 | ≥97% | 25 mg; 100 mg |
| 5-Methyl-2'-O-methylcytidine | PY 7640 | ≥97% | 100 mg; 500 mg |
| 6-Methylcytidine | PY 7641 | ≥97% | 10 mg; 25 mg |
| 5-(1-Propynyl)-2'-O-methylcytidine | PY 7660 | ≥95% | 10 mg; 50 mg |
| 5-(1-Propynyl)-2'-deoxycytidine | PY 7700 | ≥90% | 5 mg; 10 mg |
| 2-Thiocytidine | PY 7721 | ≥97% | 10 mg; 100 mg |
| 2-Thio-2'-deoxycytidine | PY 7723 | ≥95% | 10 mg; 100 mg |
| 3'-Deoxy-3',4'-didehydrocytidine | PY 7790 | ≥95% | 10 mg; 25 mg |
| Pyrrolo-dC | PYA 11090 | ≥95% | 10 mg; 100 mg |
| 6-Methyl-3-(β-D-2-ribofuranosyl)pyrrolo[2,3-d]pyrimidin-2-one | PYA 11092 | ≥97% | 10 mg; 100 mg |
| 3-(5'-O-Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-6-methylpyrrolo[2,3-d]pyrimidin-2-one | PYA 11095 | ≥95% | 100 mg; 1 g |
| 3-(2'-Deoxy-β-D-2-ribofuranosyl)pyrido[2,3-d]pyrimidine-2,7(8H)-dione | PYA 11100 | ≥95% | 10 mg; 100 mg |
| 3,N4-Etheno-2'-deoxycytidine | PYA 11130 | ≥97% | 100 mg; 500 mg |
| N6-Benzoyl-8-oxo-2'-deoxyadenosine | PR 3270 | ≥97% | 100 mg; 1 g |
| (5'S)-8,5'-Cycloadenosine | PR 3410 | ≥97% | 10 mg; 100 mg |
| (5'S)-2'-Deoxy-8,5'-cycloadenosine | PR 3420 | ≥97% | 10 mg; |
| 5'-O-(Dimethoxytrityl)-8-Oxo-N2-isobutyryl-2'-deoxyguanosine | PR 3610 | ≥97% | 100 mg; 1 g |
| 8-Oxo-2'-deoxyadenosine | PR 3705 | ≥95% | 25 mg; 250 mg |
| 8-Oxo-2'-deoxyguanosine | PR 3710 | ≥97% | 25 mg; 250 mg |
| 8-Oxo-N2-isobutyryl-2'-deoxyguanosine | PR 3720 | ≥90% | 100 mg; 1 g |
| 8-Hydroxyguanosine | PR 3795 | ≥97% | 10 mg; 100 mg |
| 8-Aza-7-deaza-2'-deoxyguanosine | PRA 10170 | ≥95% | 10 mg; 100 mg |
| 6-Amino-2-(2-deoxy-β-D-ribofuranosyl)-2,5-dihydro-4H-pyrazolo-[3,4-d]-pyrimidin-4-one | PRA 10175 | ≥95% | 10 mg; 100 mg |
| 5-Aza-2'-deoxycytidine | PY 7105 | ≥95% | 25 mg; 100 mg |
| 5,6-Dihydro-5-aza-2'-deoxycytidine | PY 7106 | ≥97% | 25 mg; 100 mg |
| 5,6-Dihydro-2'-deoxyuridine | PY 7330 | ≥97% | 100 mg; |
| (5S)-5,6-Dihydrothymidine | PY 7340 | ≥97% | 20 mg; 100 mg |
| 5-Hydroxy-2'-deoxycytidine | PY 7595 | ≥95% | 25 mg; 250 mg |
| 5-Hydroxy-2'-deoxyuridine | PY 7597 | ≥95% | 25 mg; 250 mg |
| 5-(2-Hydroxyethyl)-2'-deoxyuridine | PY 7600 | ≥95% | 25 mg; 50 mg |
| 5-Hydroxymethyl-2'-deoxyuridine | PY 7605 | ≥95% | 25 mg; 250 mg |
| 6-Methylcytidine | PY 7641 | ≥97% | 10 mg; 25 mg |
| Nap-dU | PY 7735 | ≥97% | 10 mg; 25 mg |
| NPOM-Caged deoxythymidine | PY 7795 | ≥97% | 25 mg; 100 mg |
| 3,N4-Etheno-2'-deoxycytidine | PYA 11130 | ≥97% | 100 mg; 500 mg |
| Pyrrolo-dC | PYA 11090 | ≥95% | 10 mg; 100 mg |
| 6-Methyl-3-(β-D-2-ribofuranosyl)pyrrolo[2,3-d]pyrimidin-2-one | PYA 11092 | ≥97% | 10 mg; 100 mg |
| 3-(5'-O-Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-6-methylpyrrolo[2,3-d]pyrimidin-2-one | PYA 11095 | ≥95% | 100 mg; 1 g |
| 3-(2'-Deoxy-β-D-2-ribofuranosyl)pyrido[2,3-d]pyrimidine-2,7(8H)-dione | PYA 11100 | ≥95% | 10 mg; 100 mg |
| 8-18O-Hydroxyguanosine | IOPR 3795 | ≥95% | 2 mg; 5 mg |
| 2'-Deoxyisoguanosine | PR 3465 | ≥97% | 10 mg; 100 mg |
| 5'-O-Dimethoxytrityl-N2-(trifluoroacetamido)hexyl-2'-deoxyguanosine | PR 3701 | ≥95% | 25 mg; 100 mg |
| N2-Dimethylguanosine | PR 3702 | ≥97% | 10 mg; 100 mg |
| Guanosine | PR 3703 | ≥97% | 100 g; 500 g |
| Isoguanosine | PR 3735 | ≥97% | 10 mg; 50 mg |
| O6-Methylguanosine | PR 3757 | ≥97% | 25 mg; 100 mg |
| 2'-O-Methylguanosine | PR 3760 | ≥97% | 1 g; 10 g |
| 7-Methyl-6-thioguanosine | PR 3790 | ≥75% | 25 mg; 100 mg |
| 8-Bromoguanosine | PR 3796 | ≥97% | 0 g; |
| 8-Benzyloxyguanosine | PR 3797 | ≥95% | 100 mg; 1 g |
| 7-Methyl-7-deaza-2'deoxyguanosine | PRA 10042 | ≥97% | 10 mg; 50 mg |
| 7-Deazaguanosine | PRA 10045 | ≥97% | 10 mg; 100 mg |
| 5-Amino-3-β-D-ribofuranosylthiazolo[4,5-d]pyrimidin-2,7(3H,6H)-dione | PRA 10047 | ≥97% | 10 mg; 100 mg |
| 2'-Deoxypseudoguanosine | PRA 10103 | ≥97% | 10 mg; 50 mg |
| 2'-Deoxypseudoisoguanosine | PRA 10104 | ≥97% | 10 mg; 100 mg |
| 1-(β-D-2-Deoxyribofuranosyl)-5-nitroindole | PRA 10060 | ≥97% | 100 mg; 1 g |
| 1-(β-D-2-Deoxyribofuranosyl)-4-methylindole | PRA 10070 | ≥97% | 0 g; |
| 1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-4-methylindole | PRA 10080 | ≥97% | 0 g; |
| 1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-5-nitroindole | PRA 10090 | ≥97% | 100 mg; 1 g |
| 2'-Deoxy-4-desmethylwyosine | PR 3450 | ≥95% | 100 mg; 500 mg |
| 2'-Deoxyinosine | PR 3463 | ≥97% | 10 g; 100 g |
| 5'-Azido-2',5'-dideoxyinosine | PR 3464 | ≥97% | 5 mg; 25 mg |
| 3',5'-Di-O-acetyl-2'-deoxyinosine | PR 3480 | ≥97% | 1 g; |
| 3',5'-Di-O-acetyl-O6-phenyl-2'-deoxyinosine | PR 3490 | ≥90% | 1 g; |
| 5'-O-(Dimethoxytrityl)-2'-O-methylinosine | PR 3640 | ≥97% | 1 g; |
| 5'-O-(Dimethoxytrityl)-O6-phenyl-2'-deoxyinosine | PR 3660 | ≥97% | 100 mg; 1 g |
| Inosine | PR 3725 | ≥97% | 100 g; 500 g |
| 2',3'-Dideoxyinosine | PR 3727 | ≥97% | 100 mg; 1 g |
| 2'-O-Methylinosine | PR 3770 | ≥97% | 500 mg; 1 g |
| 7-Methylinosine | PR 3780 | ≥95% | 100 mg; 250 mg |
| O6-Phenyl-2'-deoxyinosine | PR 3840 | ≥97% | 100 mg; 1 g |
| 2-Fluoro-6-O-(2-(4-nitrophenyl)ethyl)-2'-deoxyinosine | PR 3842 | ≥97% | 25 mg; |
| 5'-O-Dimethoxytrityl-2-fluoro-6-O-(2-(4-nitrophenyl)ethyl)-2'-deoxyinosine | PR 3843 | ≥90% | 25 mg; 100 mg |
| 2'-Deoxyisoguanosine | PR 3465 | ≥97% | 10 mg; 100 mg |
| N6-(Diisobutylaminomethylidene)-2'-deoxyisoguanosine | PR 3510 | ≥90% | 100 mg; 1 g |
| N6-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-O2-(diphenylcarbamoyl)-2'-deoxyisoguanosine | PR 3520 | ≥95% | 100 mg; 1 g |
| N6-(Diisobutylaminomethylidene)-O2-(diphenylcarbamoyl)-2'-deoxyisoguanosine | PR 3530 | ≥90% | 100 mg; 1 g |
| Isoguanosine | PR 3735 | ≥97% | 10 mg; 50 mg |
| d5SICS | FC 8120 | ≥97% | 25 mg; 100 mg |
| AICA Riboside (AICAR) | MN 20001 | ≥97% | 0 g (DISCONTINUED); |
| 2',3'-Di-O-methyladenosine | PR 3540 | ≥97% | 100 mg; 1 g |
| 2,6-Bis-O-[2-(4-nitrophenyl)ethyl]-2'-deoxyxanthosine | PR 3692 | ≥95% | 10 mg; 100 mg |
| 5-Amino-3-β-D-ribofuranosylthiazolo[4,5-d]pyrimidin-2,7(3H,6H)-dione | PRA 10047 | ≥97% | 10 mg; 100 mg |
| 8-Aza-7-deaza-2'-deoxyguanosine | PRA 10170 | ≥95% | 10 mg; 100 mg |
| 6-Amino-2-(2-deoxy-β-D-ribofuranosyl)-2,5-dihydro-4H-pyrazolo-[3,4-d]-pyrimidin-4-one | PRA 10175 | ≥95% | 10 mg; 100 mg |
| 3'-Deoxy-3',4'-didehydrocytidine | PY 7790 | ≥95% | 10 mg; 25 mg |
| NPOM-Caged deoxythymidine | PY 7795 | ≥97% | 25 mg; 100 mg |
| tC Nucleoside | PYA 11110 | ≥97% | 50 mg; 100 mg |
| tCnitro Nucleoside | PYA 11115 | ≥95% | 5 mg; 25 mg |
| 2'-Deoxynebularine | PR 3470 | Purity: ≥97% | 100 mg; 1 g |
| 7-Methylinosine | PR 3780 | ≥95% | 100 mg; 250 mg |
| 7-Methyl-6-thioguanosine | PR 3790 | ≥75% | 25 mg; 100 mg |
| 1-(β-D-2-Deoxyribofuranosyl)-3-nitropyrrole | PYA 11020 | ≥97% | 50 mg; |
| 1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-3-nitropyrrole | PYA 11030 | ≥95% | 100 mg; |
| Showdomycin | PYA 11056 | ≥97% | 10 mg; |
| Formycin A | PYA 11001 | ≥97% | 10 mg; |
| Formycin B | PYA 11002 | ≥97% | 10 mg; |
| Pseudouridine | PYA 11080 | ≥97% | 10 mg; |
| Pyrazofurin | PYA 11004 | ≥97% | 10 mg; |
| Toyocamycin | PRA 10150 | ≥97% | 10 mg; |
| 7-Deazaadenosine (tubercidin) | PRA 10035 | ≥97% | 10 mg; |
| Allopurinol riboside | PRA 10011 | ≥97% | 25 mg; |
| 5-Iodotubercidin | PRA 10095 | ≥90% | 5 mg; |
| Triciribine | PRA 10160 | ≥97% | 10 mg; |
| Tricyclic Nucleoside Phosphate | PRA 10162 | ≥95% | 10 mg; |
| 5-Amino-3-β-D-ribofuranosylthiazolo[4,5-d]pyrimidin-2,7(3H,6H)-dione | PRA 10047 | ≥97% | 10 mg; |
| 5'-Amino-5'-deoxythymidine | PY 7030 | ≥97% | 25 mg; 50 mg |
| O2,5'-Anhydrothymidine | PY 7060 | ≥95% | 500 mg; 1 g |
| 3'-Azido-3'-deoxythymidine (AZT) | PY 7065 | ≥97% | 500 mg; 1 g |
| 5'-Azido-5'-deoxythymidine | PY 7070 | ≥97% | 25 mg; 100 mg |
| 3'-Azido-3'-deoxy-5'-O-methylthymidine | PY 7075 | ≥97% | 0 g DISCONTINUED; |
| 3'-O-(t-Butyldimethylsilyl)-5'-deoxy-5'-(1,3-diphenyl-2-imidazolidinyl)thymidine | PY 7120 | ≥97% | 1 g; |
| 3'-O-(t-Butyldimethylsilyl)thymidine | PY 7130 | ≥95% | 500 mg; 1 g |
| 5'-O-(t-Butyldimethylsilyl)thymidine | PY 7140 | ≥97% | 5 g; 10 g |
| 3',5'-bis-O-(t-Butyldimethylsilyl)thymidine | PY 7150 | ≥97% | 1 g; 5 g |
| 3',5'-bis-O-(t-Butyldimethylsilyl)-O4-(2,4,6-triisopropylphenylsulfonyl)thymidine | PY 7160 | ≥95% | 100 mg; 500 mg |
| S4-(2-Cyanoethyl)-5'-O-(dimethoxytrityl)-4-thiothymidine | PY 7200 | ≥95% | 10 mg; 100 mg |
| S4-(2-Cyanoethyl)-4-thiothymidine | PY 7210 | ≥95% | 10 mg; 100 mg |
| 5'-Deoxy-5'-(1,3-diphenyl-2-imidazolidinyl)thymidine | PY 7250 | ≥97% | 1 g; |
| 3'-Deoxythymidine | PY 7277 | ≥95% | 50 mg; 100 mg |
| 1-(3,5-Di-O-acetyl-β-D-deoxyribofuranosyl)-4-(1,2,4-triazol-1-yl)-5-methylpyrmidin-2-one | PY 7315 | ≥90% | 1 g; 10 g |
| 2',3'-Didehydro-3'-deoxythymidine | PY 7328 | ≥95% | 10 mg; 100 mg |
| (5S)-5,6-Dihydrothymidine | PY 7340 | ≥97% | 20 mg; 100 mg |
| (5S,6R)-5',6'-Cyclo-5'-deoxy-5,6-dihydrothymidine | PY 7345 | ≥95% | 10 mg; 25 mg |
| (5S)-5'-O-(Dimethoxytrityl)-5,6-dihydrothymidine | PY 7390 | ≥97% | 100 mg; |
| 5'-O-(Dimethoxytrityl)-N3/O4-(toluoyl)-2-thiothymidine | PY 7510 | ≥97% | 50 mg; 100 mg |
| 2-O-Ethylthymidine | PY 7561 | ≥97% | 500 mg; 1 g |
| 5'-Iodo-5'-deoxythymidine | PY 7610 | ≥97% | 250 mg; 1 g |
| 5'-O-Methylthymidine | PY 7680 | ≥95% | 50 mg; 100 mg |
| 2-Thiothymidine | PY 7725 | ≥95% | 20 mg; 100 mg |
| Thymidine | PY 7727 | ≥97% | 25 g; 250 g |
| 5'-O-(p-Toluenesulfonyl)thymidine | PY 7740 | ≥97% | 5 g; |
| 3-(2-Cyanoethyl)thymidine | PY 7742 | ≥95% | 10 mg; 25 mg |
| 5'-Trifluoroacetamido-5'-deoxythymidine | PY 7750 | ≥97% | 50 mg; |
| NPOM-Caged deoxythymidine | PY 7795 | ≥97% | 25 mg; 100 mg |
| 6-Methyl-3-(β-D-2-deoxyribofuranosyl)furano-[2,3-d]pyrimidin-2-one | PYA 11055 | ≥97% | 5 mg; 25 mg |
| 6-Azathymidine | PYA 11058 | ≥95% | 25 mg; 100 mg |
| NPOM-Caged-dT CEP | BA 0317 | ≥95% | 100 µmol; 0.25 g |
| 5-[N-(2-Aminoethyl)-3-(E)-acrylamido]-5'-O-(dimethoxytrityl)-2'-deoxyuridine | PY 7040 | ≥97% | 100 mg; 1 g |
| 5-[N-(6-Aminohexyl)-3-(E)-acrylamido]-5'-O-(dimethoxytrityl)-2'-deoxyuridine | PY 7050 | ≥90% | 100 mg; 1 g |
| 3'-Azido-3'-deoxy-5'-O-methylthymidine | PY 7075 | ≥97% | 0 g DISCONTINUED; |
| (E)-5-(2-Carbomethoxyvinyl)-2'-deoxyuridine | PY 7170 | ≥97% | 1 g; |
| (E)-5-(2-Carboxyvinyl)-2'-deoxyuridine | PY 7180 | ≥97% | 500 mg; 1 g |
| (E)-5-(2-Carboxyvinyl)-2'-deoxyuridine N-Hydroxysuccinimide Ester | PY 7190 | ≥97% | 100 mg; 1 g |
| (5S,6R)-5',6'-Cyclo-5'-deoxy-5,6-dihydrothymidine | PY 7345 | ≥95% | 10 mg; 25 mg |
| 5'-O-(Dimethoxytrityl)-5-[N-(2-(trifluoroacetamido)ethyl)-3-(E)acrylamido]-2'-deoxyuridine | PY 7520 | ≥97% | 100 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-5-[N-(6-(trifluoroacetamido)hexyl)-3-(E)-acrylamido]-2'-deoxyuridine | PY 7530 | ≥97% | 100 mg; 1 g |
| 1-(3,5-Di-O-(p-toluoyl)-β-D-2-deoxyribofuranosyl)-5-(2-(phthalimidooxy)ethyl)-4-(1,2,4-triazol-1-yl)-lH-pyrimidin-2-one | PY 7550 | ≥95% | 100 mg; 1 g |
| 3',5'-Di-O-(p-toluoyl)-5-(2-hydroxyethyl)-2'-deoxyuridine | PY 7560 | ≥95% | 500 mg; 1 g |
| 5-(2-Hydroxyethyl)-2'-deoxyuridine | PY 7600 | ≥95% | 25 mg; 50 mg |
| 3-(2-Cyanoethyl)thymidine | PY 7742 | ≥95% | 10 mg; 25 mg |
| 5-[3-(Trifluoroacetamido)-E-1-propenyl]-2’-deoxyuridine | PY 7754 | ≥95% | 100 mg; 1 g |
| 5-[N(2-(Trifluoroacetamido)ethyl)-3-(E)-acrylamido]-2'-deoxyuridine | PY 7760 | ≥90% | 100 mg; 1 g |
| 5-[N(6-(Trifluoroacetamido)hexyl)-3-(E)-acrylamido]-2'-deoxyuridine | PY 7770 | ≥95% | 100 mg; 1 g |
| NPOM-Caged deoxythymidine | PY 7795 | ≥97% | 25 mg; 100 mg |
| 6-Methyl-3-(β-D-2-deoxyribofuranosyl)furano-[2,3-d]pyrimidin-2-one | PYA 11055 | ≥97% | 5 mg; 25 mg |
| 5-Ethynyl uridine CEP | BA 0353 | ≥90% | 100 µmol; 0.25 g |
| 2'-O-Acetyl-5'-O-benzoyl-5-methyl-3'-deoxyuridine | PY 7000 | ≥97% | 500 mg; 1 g |
| 5-[N-(2-Aminoethyl)-3-(E)-acrylamido]-5'-O-(dimethoxytrityl)-2'-deoxyuridine | PY 7040 | ≥97% | 100 mg; 1 g |
| 5-[N-(6-Aminohexyl)-3-(E)-acrylamido]-5'-O-(dimethoxytrityl)-2'-deoxyuridine | PY 7050 | ≥90% | 100 mg; 1 g |
| 5-(Furan-2-yl)-2'-deoxyuridine | PY 7053 | ≥97% | 25 mg; 100 mg |
| 1-(β-D-2-Deoxyribofuranosyl)-4-(1,2,4-triazol-1-yl)pyrimidin-2-one | PY 7055 | ≥97% | 20 mg; 100 mg |
| 5-Bromo-2'-deoxyuridine | PY 7117 | ≥97% | 10 g; 25 g |
| 5-Bromouridine | PY 7118 | ≥95% | 5 g; |
| (E)-5-(2-Carbomethoxyvinyl)-2'-deoxyuridine | PY 7170 | ≥97% | 1 g; |
| (E)-5-(2-Carbomethoxyvinyl)uridine | PY 7172 | ≥97% | 25 mg; 250 mg |
| (E)-5-(2-Carboxyvinyl)-2'-deoxyuridine | PY 7180 | ≥97% | 500 mg; 1 g |
| (E)-5-(2-Carboxyvinyl)uridine | PY 7185 | ≥97% | 1 g; |
| (E)-5-(2-Carboxyvinyl)-2'-deoxyuridine N-Hydroxysuccinimide Ester | PY 7190 | ≥97% | 100 mg; 1 g |
| S4-(2-Cyanoethyl)-4-thio-2'-deoxyuridine | PY 7212 | ≥95% | 10 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-5-methyl-3'-deoxyuridine | PY 7240 | ≥95% | 25 mg; 100 mg |
| 5-Methyl-3'-deoxyuridine | PY 7260 | ≥95% | 20 mg; 50 mg |
| 2'-Deoxyuridine | PY 7275 | ≥97% | 25 g; 100 g |
| 3',5'-Di-O-acetyl-5-fluoro-2'-deoxyuridine | PY 7280 | ≥95% | 100 mg; 500 mg |
| 3'-Azido-2',3'-dideoxy-5-bromouridine | PY 7286 | ≥97% | 10 mg; 50 mg |
| 3',5'-Di-O-acetyl-5-fluoro-O4-(2,4,6-trimethylphenyl)-2'-O-methyluridine | PY 7290 | ≥95% | 500 mg; 1 g |
| 3',5'-Di-O-acetyl-5-fluoro-2'-O-methyluridine | PY 7300 | ≥97% | 50 mg; 250 mg |
| 3',5'-Di-O-acetyl-5-fluoro-O4-(2,4,6-trimethylphenyl)-2'-deoxyuridine | PY 7310 | ≥97% | 20 mg; 50 mg |
| 3',5'-Di-O-benzoyl-5-fluoro-2'-O-methyluridine | PY 7320 | ≥97% | 500 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-5-fluoro-2'-O-methyluridine | PY 7420 | ≥95% | 100 mg; 500 mg |
| 5'-O-(Dimethoxytrityl)-5-iodo-2'-deoxyuridine | PY 7450 | ≥97% | 500 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-5-iodo-2'-O-methyluridine | PY 7460 | ≥97% | 50 mg; 100 mg |
| 5-Methoxymethyl-2'-deoxyuridine | PY 7465 | ≥95% | 10 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-5-methyl-2'-O-methyluridine | PY 7470 | ≥97% | 100 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-2'-O-methyluridine | PY 7480 | ≥97% | 500 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-deoxyuridine | PY 7490 | ≥95% | 50 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-O-methyluridine | PY 7500 | ≥95% | 25 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-5-[N-(2-(trifluoroacetamido)ethyl)-3-(E)acrylamido]-2'-deoxyuridine | PY 7520 | ≥97% | 100 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-5-[N-(6-(trifluoroacetamido)hexyl)-3-(E)-acrylamido]-2'-deoxyuridine | PY 7530 | ≥97% | 100 mg; 1 g |
| 1-(3,5-Di-O-(p-toluoyl)-β-D-2-deoxyribofuranosyl)-5-(2-(phthalimidooxy)ethyl)-4-(1,2,4-triazol-1-yl)-lH-pyrimidin-2-one | PY 7550 | ≥95% | 100 mg; 1 g |
| 3',5'-Di-O-(p-toluoyl)-5-(2-hydroxyethyl)-2'-deoxyuridine | PY 7560 | ≥95% | 500 mg; 1 g |
| 5-Ethynyl-2'-deoxyuridine | PY 7562 | ≥97% | 25 mg; 100 mg |
| 5-Ethynyl uridine | PY 7563 | ≥97% | 10 mg; 100 mg |
| 5-Fluoro-2'-deoxyuridine | PY 7565 | ≥97% | 100 mg; 1 g |
| 5-Fluoro-2'-O-methyluridine | PY 7570 | ≥97% | 50 mg; 100 mg |
| 5-Fluoro-O4-(2,4,6-trimethylphenyl)-2'-deoxyuridine | PY 7580 | ≥97% | 25 mg; 100 mg |
| 5-Fluoro-O4-(2,4,6-trimethylphenyl)-2'-O-methyluridine | PY 7590 | ≥95% | 25 mg; 100 mg |
| 5-Hydroxy-2'-deoxyuridine | PY 7597 | ≥95% | 25 mg; 250 mg |
| 5-(2-Hydroxyethyl)-2'-deoxyuridine | PY 7600 | ≥95% | 25 mg; 50 mg |
| 5-Acetoxymethyl-2'-deoxyuridine | PY 7604 | ≥97% | 25 mg; 100 mg |
| 5-Hydroxymethyl-2'-deoxyuridine | PY 7605 | ≥95% | 25 mg; 250 mg |
| 2'-Fluoro-5'-iodo deoxyuridine | PY 7612 | ≥95% | 100 mg; |
| 5-Iodo-2'-deoxyuridine | PY 7615 | ≥97% | 10 g; 25 g |
| 5-Iodo-2'-O-methyluridine | PY 7630 | ≥97% | 100 mg; 1 g |
| 5-Iodouridine | PY 7632 | ≥95% | 5 g; 25 g |
| 5-Methyl-2'-O-methyluridine | PY 7650 | ≥97% | 100 mg; 1 g |
| 5-(1-Propynyl)-2'-O-methyluridine | PY 7670 | ≥97% | 10 mg; 25 mg |
| 2'-O-Methyluridine | PY 7690 | ≥97% | 5 g; |
| 3-Methyluridine | PY 7694 | ≥97% | 25 mg; 100 mg |
| 5-Methyluridine | PY 7695 | ≥97% | 200 mg; 1 g |
| 5-(1-Propynyl)-2'-deoxyuridine | PY 7710 | ≥97% | 100 mg; 1 g |
| 5-(Propargyloxy)-2'-deoxyuridine | PY 7712 | ≥95% | 10 mg; 100 mg |
| Zebularine | PY 7715 | ≥97% | 10 mg; 25 mg |
| 3',5'-O-(1,1,3,3-Tetraisopropyl-1,3-disiloxanediyl)-2'-deoxyuridine | PY 7720 | ≥90% | 500 mg; 1 g |
| 2-Thiouridine | PY 7724 | ≥97% | 25 mg; 100 mg |
| 5'-O-(p-Toluenesulfonyl)-2'-deoxyuridine | PY 7730 | ≥97% | 1 g; 5 g |
| 5-[3-(Trifluoroacetamido)-E-1-propenyl]-2’-deoxyuridine | PY 7754 | ≥95% | 100 mg; 1 g |
| 5-[3-(Trifluoroacetamido)-1-(E)-propenyl]uridine | PY 7758 | ≥97% | 100 mg; 1 g |
| 5-[N(2-(Trifluoroacetamido)ethyl)-3-(E)-acrylamido]-2'-deoxyuridine | PY 7760 | ≥90% | 100 mg; 1 g |
| 5-[N(6-(Trifluoroacetamido)hexyl)-3-(E)-acrylamido]-2'-deoxyuridine | PY 7770 | ≥95% | 100 mg; 1 g |
| 5-[N-(6-(Trifluoracetamido)hexyl)-(E)-acrylamido]uridine | PY 7775 | ≥97% | 100 mg; 1 g |
| Uridine | PY 7780 | ≥97% | 100 g; 500 g |
| 2'3'-O-Isopropylidene uridine | PY 7781 | ≥97% | 5 g; 25 g |
| 5-Hydroxymethyl uridine | PY 7782 | ≥97% | 50 mg; 100 mg |
| 5-Methoxyuridine | PY 7783 | ≥97% | 10 mg; 50 mg |
| 6-Aza-2'-deoxyuridine | PYA 11057 | ≥95% | 50 mg; 100 mg |
" data-original="http://pharna.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Berry & Associates全系列修饰核苷酸"> 艾美捷科技代理Berry & Associates全系列修饰核苷酸

Molecular Innovations公司为全球的研究人员提供高质量的科研产品,包括纤溶酶原激活物抑制因子1,肾素,肾素原,玻连蛋白,纤维蛋白,纤维连接蛋白,血纤维蛋白溶酶原,血纤维蛋白溶酶,抗凝血酶,ELISA试剂盒,抗体和其他研究使用的试剂。
Molecular Innovations, founded in 1990, is a primary manufacturer of research antibodies, proteins and ELISA kits. We specialize in coagulation and thrombolysis reagents including PAI-1, tPA, urokinase, clotting factors, vitronectin, fibrinogen, fibronectin, clotting factors, prorenin/renin, albumin, and immunoglobulins. Our customers all over the world include pharmaceutical and biotechnology companies as well as major research institutions. We offer custom projects and bulk quotes. All products are manufactured under stringent quality control standards at our new state of the art facility in Novi, MI, USA.
Molecular innovations的主要产品包括:
Research Models
Molecular Biology
Purified Proteins
Elisa Kits
Monoclonal Antibodies
Polyclonal Antibodies
Inhibitors And Substrates
Chromatography Resins
Plasmas And Tissues
<更多详情请联系
艾美捷科技有限公司
全国服务热线:400-6800-868
邮箱:sales@amyjet.com
网站:www.amyjet.com

TOKU-E公司专注于体外抗生素生产技术,并快速成长为世界领先的超纯抗生素供应者,以低廉的价格提供最全面的超纯抗生素,其纯度大于99%,用于动物细胞培养、植物组织培养、微生物、抗真菌及诊断等科研领域,允许研究者提高抗生素浓度,并消除污染,降低对细胞的伤害,从而提高筛选效率;该公司还提供精细化学试剂,如超纯丙烯酰胺、无尘SDS、胍盐等,极大提高了实验的精确性和安全性,可满足生命科学研究领域各科研机构,标准化组织机构的高标准需求。
When our doors first opened in 1981, we were a chemical trading company in Tokyo, Japan called TOKUICHI, which means‘moral first’in Japanese. Having established a firm foundation, our company focused on manufacturing antibiotics through fermentation, then specialized in pharma and biotech research sectors. To reflect our growth into a leading global antibiotic manufacturer, we updated our name to TOKU-E. Though we have expanded our scope to better serve our customers, we still maintain our strong moral fiber.
TOKU-E has facilities in the US, China, Europe, and Singapore to serve you globally, and our network of worldwide distributors offers region-specific expertise. Our company is ISO 9001:2015 certified, for your regulatory peace of mind.
TOKU-E的主要产品包括:
(1)Cell Culture
Gene Selection Antibiotics
Contamination Control
Mycoplasma Detection & Elimination
(2)Cancer Research
Antitumor
Chemotherapeutics
Immunosuppressants
(3)Microbiology
Antimicrobials
Gene Selection Antibiotics
Beta-lactamase Inhibitors
Nitrocefin
Selective Agents
(4)Plant Biology
<更多详情请联系
艾美捷科技有限公司
全国服务热线:400-6800-868
邮箱:sales@amyjet.com
网站:www.amyjet.com
" data-original="http://pharna.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="TOKU-E"> TOKU-E
Salimetrics是一家全球著名的唾液生物学研究领域专业产品供应商,其在唾液的收集方法、生物学性质及其(唾液中各生物组分的含量)定量检测技术拥有绝对的研发与产品供应优势。作为唾液生物学研究及诊断试剂盒应用领域的行业标准,其供应的唾液手机方案及唾液成分的ELISA检测试剂盒均专门唾液的理化性质所设计,可确保客户在科学研究或临床诊断中得到稳定、准确的唾液生物学信息,并同时具有操作简便、结果精确可靠、可重复性高、耗时少等诸多优点。Salimetrics的唾液检测实验室及拥有丰富的唾液生物学研发经验的专业团队可以为广大客户提供唾液生物学研究及诊断应用的专业指导。
<更多详情请联系
艾美捷科技有限公司
全国服务热线:400-6800-868
邮箱:sales@amyjet.com
网站:www.amyjet.com
产品名称 | 产品编号 | 产品参数 |
Salivary 17 Alpha-OHP ELISA Kit | 1-2602 | Catalog#: 1-2602 |
Salivary Alpha-Amylase Enzymatic Kit | 1-1902 | Catalog#:1-1902 |
Salivary Androstenedione ELISA Kit | 1-2902 | Catalog#:1-2902 |
Salivary C-Reactive Protein ELISA Kit | 1-2102 | Catalog#:1-2102 |
Salivary Cortisol ELISA Kit | 1-3002 | Catalog#:1-3002 |
Salivary Cotinine ELISA Kit | 1-2002 | Catalog#:1-2002 |
Salivary DHEA ELISA Kit | 1-1202 | Catalog#:1-1202 |
Salivary DHEA-S ELISA Kit | 1-1252 | Catalog#:1-1252 |
Salivary Estradiol ELISA Kit | 1-3702 | Catalog#:1-3702 |
Salivary Estriol ELISA Kit | 1-1802 | Catalog#:1-1802 |
HS Salivary Estriol ELISA Kit | 1-1802 | Catalog#:1-1802 |
Salivary Estrone ELISA Kit | 1-3202 | Catalog#:1-3202 |
Salivary Interleukin-1 Beta ELISA Kit | 1-3902 | Catalog#:1-3902 |
Salivary Interleukin-6 ELISA Kit | 1-3602 | Catalog#: 1-3602 |
Salivary Melatonin ELISA Kit | 1-3402 | Catalog#:1-3402 |
Salivary Progesterone ELISA Kit | 1-1502 | Catalog#:1-1502 |
Salivary Secretory IgA ELISA Kit | 1-1602 | Catalog#:1-1602 |
Salivary Testosterone ELISA Kit | 1-2402 | Catalog#:1-2402 |
Salivary Transferrin/Blood Contamination ELISA Kit | 1-1302 | Catalog#:1-1302 |
Salivary Uric Acid Assay Kit | 1-3802 | Catalog#:1-3802 |
Diagnostic Salivary Cortisol ELISA Kit (FDA, CE Mark) | 1-3102 | Catalog#:1-3102 |
Diagnostic Salivary Cotinine ELISA Kit (FDA, CE Mark) | 1-2112 | Catalog#:1-2112 |
Diagnostic Salivary DHEA ELISA Kit (CE Mark) | 1-2212 | Catalog#:1-2212 |
Diagnostic Salivary Estradiol ELISA Kit (FDA, CE Mark) | 1-3702 | Catalog#:1-3702 |
Diagnostic Salivary Estriol ELISA Kit (CE Mark) | 1-2812 | Catalog#:1-2812 |
Diagnostic Salivary Progesterone ELISA Kit (FDA, CE Mark) | 1-2502 | Catalog#:1-2502 |
Diagnostic Testosterone ELISA Kit (CE Mark) | 1-2312 | Catalog#:1-2312 |

List Labs公司成立于1978年,位于美国加州硅谷,是一家专业提供各类微生物Toxin的生物技术公司。
Our company was founded in 1978 by Linda Shoer. Cholera toxin, the first product, was sought after by those doing research in signal transduction and by others using the toxin B subunit to label neurons. At that time there were no commercial suppliers of this toxin. Our company has always focused on quality bacterial toxins, which you can depend on for your research. Because toxins have been the basis for many vaccines, List Labs products have supported vaccine development. List Labs was the first to commercialize many bacterial toxins for research, including C.difficile toxins and pertussis toxin. Today, we remain uniquely focused on manufacturing, offering and supporting a wide range of bacterial products.
List Labs' heart is in the science and the discovery of innovative reagents. Our office is located in Campbell, California, in Silicon Valley. We serve the global research community with an expanding group of distributors. Years of experience translate into expertise in the production, shipment and handling of dangerous goods. If you have questions about any of our products or services, contact us.
List Biological Labs的主要产品包括:
Anthrax Toxins
Antisera & Antibodies
Botulinum Toxins
Cholera Toxins
Difficile Toxins
Diphtheria Toxin & Crm
Exotoxin A
Fret Peptides, Native Substrates & Receptors
Lipopolysaccharides
Pertussis Toxins & Virulence Factors
Shiga Toxins
Staphylococcal Toxins
Tetanus Toxins & Related Products
Toxoids
Vaccine Carrier Proteins And Adjuvants
<更多详情请联系
艾美捷科技有限公司
全国服务热线:400-6800-868
邮箱:sales@amyjet.com
网站:www.amyjet.com
" data-original="http://pharna.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="List Labs"> List Labs艾美捷科技授权代理Bioclone品牌全系列产品。
【快速入口】
丁香通:https://vicbio.biomart.cn/supply/c_cate-582257.htm
艾美捷科技商城:http://www.amyjet.com/Index/lists/catid/27/kid/74.html
【品牌介绍】

美国Bioclone Inc.公司成立已逾20年,其独特的“一步法”生物磁分离技术,已经在全球生物科学研究领域得到广泛应用,无论是大规模批量生产还是微量的生物样品处理,该技术都具有快速、简单、操作灵活的优势,目前是磁珠行业内先进技术的领跑者。我司代理Bioclone产品范围包括:负向磁珠、法医类试剂盒、蛋白纯化试剂、荧光磁珠、免疫磁珠、离子交换磁珠、反相磁珠及其他试剂盒等。
【一步法纯化平台】

【产品列表】
| 货号 | 中文名称 | 规格 | 价格(人民币) |
| FA101 | 1µm BcMag™ 氨基磁珠 150mg | 150mg | 4125 |
| FA102 | 1µm BcMag™ 氨基磁珠 300mg | 300mg | 7875 |
| FA103 | 5µm BcMag™ 氨基磁珠 150mg | 150mg | 4125 |
| FA104 | 5µm BcMag™ 氨基磁珠 300mg | 300mg | 7875 |
| FA105 | 1µm BcMag™ DADPA活化磁珠 150mg | 150mg | 4875 |
| FA106 | 2µm BcMag™ DADPA活化磁珠 300mg | 300mg | 9150 |
| FA107 | 5µm BcMag™ DADPA活化磁珠 150mg | 150mg | 4875 |
| FA108 | 5µm BcMag™ DADPA活化磁珠 300mg | 300mg | 9150 |
| FA113 | 1µm BcMag™ 长链氨基磁珠 150mg | 150mg | 4875 |
| FA114 | 1µm BcMag™ 长链氨基磁珠 300mg | 300mg | 9150 |
| FA115 | 5µm BcMag™ 长链氨基磁珠 150mg | 150mg | 4875 |
| FA116 | 5µm BcMag™ 长链氨基磁珠 300mg | 300mg | 9150 |
| FB101 | 1µm BcMag™ 羧基磁珠 150mg | 150mg | 4125 |
| FB102 | 1µm BcMag™ 羧基磁珠 300mg | 300mg | 7875 |
| FB103 | 5µm BcMag™ 羧基磁珠 150mg | 150mg | 4125 |
| FB104 | 5µm BcMag™ 羧基磁珠 300mg | 300mg | 7875 |
| FB105 | 1µm BcMag™ 长链羧基磁珠 150mg | 150mg | 4875 |
| FB106 | 1µm BcMag™ 长链羧基磁珠 300mg | 300mg | 9150 |
| FB107 | 5µm BcMag™ 长链羧基磁珠 150mg | 150mg | 4875 |
| FB108 | 5µm BcMag™ 长链羧基磁珠 300mg | 300mg | 9150 |
| FB113 | BcMag™ 羧基磁珠偶连试剂盒 | Kit | 4125 |
| FC101 | 1µm BcMag™ 环氧基活化磁珠 150mg | 150mg | 4125 |
| FC102 | 1µm BcMag™ 环氧基活化磁珠 300mg | 300mg | 7875 |
| FC103 | 5µm BcMag™ 环氧基活化磁珠 150mg | 150mg | 4125 |
| FC104 | 5µm BcMag™ 环氧基活化磁珠 300mg | 300mg | 7875 |
| FC105 | 1µm BcMag™ 长链环氧基活化磁珠 150mg | 150mg | 4875 |
| FC106 | 1µm BcMag™ 长链环氧基活化磁珠 300mg | 300mg | 9150 |
| FC107 | 5µm BcMag™ 长链环氧基活化磁珠 150mg | 150mg | 4875 |
| FC108 | 5µm BcMag™ 长链环氧基活化磁珠 300mg | 300mg | 9150 |
| FC109 | BcMag™ 环氧基活化磁珠偶连试剂盒 | Kit | 4125 |
| FD101 | 1µm BcMag™ 酰肼基磁珠 150mg | 150mg | 4125 |
| FD102 | 1µm BcMag™ 酰肼基磁珠 300mg | 300mg | 7875 |
| FD103 | 5µm BcMag™ 酰肼基磁珠 150mg | 150mg | 4125 |
| FD104 | 5µm BcMag™ 酰肼基磁珠 300mg | 300mg | 7875 |
| FD105 | BcMag™ 酰肼基磁珠偶连试剂盒 | Kit | 4125 |
| FD106 | BcMag™ 糖蛋白和抗体结合试剂盒,含1um酰肼磁珠 kit | kit | 5250 |
| FD107 | BcMag™ 糖蛋白和抗体结合试剂盒,含1um可洗脱式酰肼磁珠 kit | kit | 6750 |
| FE101 | 1µm BcMag™ 醛基磁珠 150mg | 150mg | 4125 |
| FE102 | 1µm BcMag™ 醛基磁珠 300mg | 300mg | 7875 |
| FE103 | 5µm BcMag™ 醛基磁珠 150mg | 150mg | 4125 |
| FE104 | 5µm BcMag™ 醛基磁珠 300mg | 300mg | 7875 |
| FE105 | 1µm BcMag™ 长链醛基磁珠 150mg | 150mg | 4875 |
| FE106 | 1µm BcMag™ 长链醛基磁珠 300mg | 300mg | 9150 |
| FE107 | 5µm BcMag™ 长链醛基磁珠 150mg | 150mg | 4875 |
| FE108 | 5µm BcMag™ 长链醛基磁珠 300mg | 300mg | 9150 |
| FE109 | BcMag™ 醛基磁珠偶连试剂盒 | Kit | 4125 |
| FF101 | 1µm BcMag™ 二氧化硅改良磁珠磁珠 150mg | 150mg | 3750 |
| FF102 | 1µm BcMag™ 二氧化硅改良磁珠磁珠 300mg | 300mg | 6750 |
| FF103 | 5µm BcMag™ 二氧化硅改良磁珠磁珠 150mg | 150mg | 3750 |
| FF104 | 5µm BcMag™ 二氧化硅改良磁珠磁珠 300mg | 300mg | 6750 |
| FF105 | 1µm BcMag™ IDA磁珠 5ml | 5ml | 4125 |
| FF106 | 1µm BcMag™ IDA磁珠 10ml | 10ml | 7875 |
| FF109 | 5µm BcMag™ IDA磁珠 150mg | 150mg | 4125 |
| FF110 | 5µm BcMag™ IDA磁珠 300mg | 300mg | 7875 |
| FG101 | 1µm BcMag™ 碘乙酰基活性磁珠 150mg | 150mg | 4125 |
| FG102 | 1µm BcMag™ 碘乙酰基活性磁珠 300mg | 300mg | 7875 |
| FG103 | 5µm BcMag™ 碘乙酰基活性磁珠 150mg | 150mg | 4125 |
| FG104 | 5µm BcMag™ 碘乙酰基活性磁珠 300mg | 300mg | 7875 |
| FG105 | 1µm BcMag™ 长链碘乙酰基活性磁珠 150mg | 150mg | 4875 |
| FG106 | 1µm BcMag™ 长链碘乙酰基活性磁珠 300mg | 300mg | 9150 |
| FG107 | 5µm BcMag™ 长链碘乙酰基活性磁珠 150mg | 150mg | 4875 |
| FG108 | 5µm BcMag™ 长链碘乙酰基活性磁珠 300mg | 300mg | 9150 |
| FG109 | BcMag™ 多肽偶联试剂盒,含1um碘乙酰基磁珠 Kit | Kit | 5250 |
| FG110 | BcMag™ 多肽偶联试剂盒,含1um可洗脱式碘乙酰基磁珠 Kit | Kit | 6750 |
| FG113 | BcMag™ 碘乙酰基磁珠偶连试剂盒 | Kit | 4125 |
| FH101 | 1µm BcMag™ DVS磁珠 150mg | 150mg | 4125 |
| FH102 | 1µm BcMag™ DVS磁珠 300mg | 300mg | 7875 |
| FH103 | 5µm BcMag™ DVS磁珠 150mg | 150mg | 4125 |
| FH104 | 5µm BcMag™ DVS磁珠 300mg | 300mg | 7875 |
| FI101 | 1µm BcMag™ NHS(N-羟基琥珀酰亚胺)磁珠 150mg | 150mg | 4125 |
| FI102 | 1µm BcMag™ NHS(N-羟基琥珀酰亚胺)磁珠 300mg | 300mg | 7875 |
| FI103 | 5µm BcMag™ NHS(N-羟基琥珀酰亚胺)磁珠 150mg | 150mg | 4125 |
| FI104 | 5µm BcMag™ NHS(N-羟基琥珀酰亚胺)磁珠 300mg | 300mg | 7875 |
| FI105 | 1µm BcMag™ 长链NHS(N-羟基琥珀酰亚胺)磁珠 150mg | 150mg | 4875 |
| FI106 | 1µm BcMag™ 长链NHS(N-羟基琥珀酰亚胺)磁珠 300mg | 300mg | 9150 |
| FI107 | 5µm BcMag™ 长链NHS(N-羟基琥珀酰亚胺)磁珠 150mg | 150mg | 4875 |
| FI108 | 5µm BcMag™ 长链NHS(N-羟基琥珀酰亚胺)磁珠 300mg | 300mg | 9150 |
| FI109 | BcMag™ NHS磁珠偶连试剂盒 | Kit | 4125 |
| FJ101 | 1µm BcMag™ 羟基磁珠 150mg | 150mg | 4125 |
| FJ102 | 1µm BcMag™ 羟基磁珠 300mg | 300mg | 7875 |
| FJ103 | 5µm BcMag™ 羟基磁珠 150mg | 150mg | 4125 |
| FJ104 | 5µm BcMag™ 羟基磁珠 300mg | 300mg | 7875 |
| FJ105 | 1µm BcMag™ 长链羟基磁珠 150mg | 150mg | 4875 |
| FJ106 | 1µm BcMag™ 长链羟基磁珠 300mg | 300mg | 9150 |
| FJ107 | 5µm BcMag™ 长链羟基磁珠 150mg | 150mg | 4875 |
| FJ108 | 5µm BcMag™ 长链羟基磁珠 300mg | 300mg | 9150 |
| FP101 | 1µm BcMag™ 巯基磁珠 150mg | 150mg | 4125 |
| FP102 | 1µm BcMag™ 巯基磁珠 300mg | 300mg | 7875 |
| FP103 | 5µm BcMag™ 巯基磁珠 150mg | 150mg | 4125 |
| FP104 | 5µm BcMag™ 巯基磁珠 300mg | 300mg | 7875 |
| FP105 | 1µm BcMag™ 长链巯基磁珠 150mg | 150mg | 4875 |
| FP106 | 1µm BcMag™ 长链巯基磁珠 300mg | 300mg | 9150 |
| FP107 | 5µm BcMag™ 长链巯基磁珠 150mg | 150mg | 4875 |
| FP108 | 5µm BcMag™ 长链巯基磁珠 300mg | 300mg | 9150 |
| FR101 | 1µm BcMag™ 对甲苯磺酰基磁珠 150mg | 150mg | 4125 |
| FR102 | 1µm BcMag™ 对甲苯磺酰基磁珠 300mg | 300mg | 7875 |
| FR103 | 5µm BcMag™ 对甲苯磺酰基磁珠 150mg | 150mg | 4125 |
| FR104 | 5µm BcMag™ 对甲苯磺酰基磁珠 300mg | 300mg | 7875 |
| FR105 | 1µm BcMag™ 长链对甲苯磺酰基磁珠 150mg | 150mg | 4875 |
| FR106 | 1µm BcMag™ 长链对甲苯磺酰基磁珠 300mg | 300mg | 9150 |
| FR107 | 5µm BcMag™ 长链对甲苯磺酰基磁珠 150mg | 150mg | 4875 |
| FR108 | 5µm BcMag™ 长链对甲苯磺酰基磁珠 300mg | 300mg | 9150 |
| FW101 | 1µm BcMag™ CDI磁珠 150mg | 150mg | 4125 |
| FW102 | 1µm BcMag™ CDI磁珠 300mg | 300mg | 7875 |
| FW103 | 5µm BcMag™ CDI磁珠 150mg | 150mg | 4125 |
| FW104 | 5µm BcMag™ CDI磁珠 300mg | 300mg | 7875 |
| FW111 | BcMag™ CDI磁珠偶连试剂盒 | Kit | 4125 |
| FX101 | 1µm BcMag™ 硫醇基磁珠 150mg | 150mg | 4125 |
| FX102 | 1µm BcMag™ 硫醇基磁珠 300mg | 300mg | 7875 |
| FX103 | 5µm BcMag™ 硫醇基磁珠 150mg | 150mg | 4125 |
| FX104 | 5µm BcMag™ 硫醇基磁珠 300mg | 300mg | 7875 |
| FX105 | 1µm BcMag™ 长链硫醇基磁珠 150mg | 150mg | 4875 |
| FX106 | 1µm BcMag™ 长链硫醇基磁珠 300mg | 300mg | 9150 |
| FX107 | 5µm BcMag™ 长链硫醇基磁珠 150mg | 150mg | 4875 |
| FX108 | 5µm BcMag™ 长链硫醇基磁珠 300mg | 300mg | 9150 |
| IL101 | 1µm BcMag™ 炔基磁珠 150mg | 150mg | 4125 |
| IL102 | 1µm BcMag™ 炔基磁珠 300mg | 300mg | 7875 |
| IL103 | 5µm BcMag™ 炔基磁珠 150mg | 150mg | 4125 |
| IL104 | 5µm BcMag™ 炔基磁珠 300mg | 300mg | 7875 |
| IM101 | 1µm BcMag™ 叠氮基活化磁珠 150mg | 150mg | 4125 |
| IM102 | 1µm BcMag™ 叠氮基活化磁珠 300mg | 300mg | 7875 |
| IM103 | 5µm BcMag™ 叠氮基活化磁珠 150mg | 150mg | 4125 |
| IM104 | 5µm BcMag™ 叠氮基活化磁珠 300mg | 300mg | 7875 |
| IA101 | 1µm BcMag™ 可洗脱式氨基磁珠 150mg | 150mg | 5625 |
| IA102 | 1µm BcMag™ 可洗脱式氨基磁珠 300mg | 300mg | 9750 |
| IA103 | 2.5µm BcMag™ 可洗脱式氨基磁珠 150mg | 150mg | 5625 |
| IA104 | 2.5µm BcMag™ 可洗脱式氨基磁珠 300mg | 300mg | 9750 |
| IB101 | 1µm BcMag™ 可洗脱式羧基磁珠 150mg | 150mg | 5625 |
| IB102 | 1µm BcMag™ 可洗脱式羧基磁珠 300mg | 300mg | 9750 |
| IB103 | 2.5µm BcMag™ 可洗脱式羧基磁珠 150mg | 150mg | 5625 |
| IB104 | 2.5µm BcMag™ 可洗脱式羧基磁珠 300mg | 300mg | 9750 |
| IC101 | 1µm BcMag™ 可洗脱式环氧基活化磁珠 150mg | 150mg | 5625 |
| IC102 | 1µm BcMag™ 可洗脱式环氧基活化磁珠 300mg | 300mg | 9750 |
| IC103 | 2.5µm BcMag™ 可洗脱式环氧基活化磁珠 150mg | 150mg | 5625 |
| IC104 | 2.5µm BcMag™ 可洗脱式环氧基活化磁珠 300mg | 300mg | 9750 |
| ID101 | 1µm BcMag™ 可洗脱式酰肼基磁珠 150mg | 150mg | 5625 |
| ID102 | 1µm BcMag™ 可洗脱式酰肼基磁珠 300mg | 300mg | 9750 |
| ID103 | 2.5µm BcMag™ 可洗脱式酰肼基磁珠 150mg | 150mg | 5625 |
| ID104 | 2.5µm BcMag™ 可洗脱式酰肼基磁珠 300mg | 300mg | 9750 |
| IE101 | 1µm BcMag™ 可洗脱式醛基磁珠 150mg | 150mg | 5625 |
| IE102 | 1µm BcMag™ 可洗脱式醛基磁珠 300mg | 300mg | 9750 |
| IE103 | 2.5µm BcMag™ 可洗脱式醛基磁珠 150mg | 150mg | 5625 |
| IE104 | 2.5µm BcMag™ 可洗脱式醛基磁珠 300mg | 300mg | 9750 |
| IG101 | 1µm BcMag™ 可洗脱式碘乙酰基活性磁珠 150mg | 150mg | 5625 |
| IG102 | 1µm BcMag™ 可洗脱式碘乙酰基活性磁珠 300mg | 300mg | 9750 |
| IG103 | 2.5µm BcMag™ 可洗脱式碘乙酰基活性磁珠 150mg | 150mg | 5625 |
| IG104 | 2.5µm BcMag™ 可洗脱式碘乙酰基活性磁珠 300mg | 300mg | 9750 |
| II101 | 1µm BcMag™ 可洗脱式NHS(N-羟基琥珀酰亚胺)磁珠 150mg | 150mg | 5625 |
| II102 | 1µm BcMag™ 可洗脱式NHS(N-羟基琥珀酰亚胺)磁珠 300mg | 300mg | 9750 |
| II103 | 2.5µm BcMag™ 可洗脱式NHS(N-羟基琥珀酰亚胺)磁珠 150mg | 150mg | 5625 |
| II104 | 2.5µm BcMag™ 可洗脱式NHS(N-羟基琥珀酰亚胺)磁珠 300mg | 300mg | 9750 |
| IJ101 | 1µm BcMag™ 可洗脱式叠氮基活化磁珠 150mg | 150mg | 5625 |
| IJ102 | 1µm BcMag™ 可洗脱式叠氮基活化磁珠 300mg | 300mg | 9750 |
| IJ103 | 2.5µm BcMag™ 可洗脱式叠氮基活化磁珠 150mg | 150mg | 5625 |
| IJ104 | 2.5µm BcMag™ 可洗脱式叠氮基活化磁珠 300mg | 300mg | 9750 |
| IK101 | 1µm BcMag™ 可洗脱式 炔基磁珠 150mg | 150mg | 5625 |
| IK102 | 1µm BcMag™ 可洗脱式 炔基磁珠 300mg | 300mg | 9750 |
| IK103 | 2.5µm BcMag™ 可洗脱式 炔基磁珠 150mg | 150mg | 5625 |
| IK104 | 2.5µm BcMag™ 可洗脱式 炔基磁珠 300mg | 300mg | 9750 |
| IR101 | 1µm BcMag™ 可洗脱式 对甲苯磺酰基磁珠 150mg | 150mg | 5625 |
| IR102 | 1µm BcMag™ 可洗脱式对甲苯磺酰基磁珠 300mg | 300mg | 9750 |
| IR103 | 2.5µm BcMag™ 可洗脱式对甲苯磺酰基磁珠 150mg | 150mg | 5625 |
| IR104 | 2.5µm BcMag™ 可洗脱式对甲苯磺酰基磁珠 300mg | 300mg | 9750 |
| AA101 | BcMag™ 一步法哺乳动物细胞DNA提取纯化试剂盒 50 preps | 50 preps | 3750 |
| AA102 | BcMag™ 一步法哺乳动物细胞DNA提取纯化试剂盒 100 preps | 100 preps | 6750 |
| AE101 | BcMag™ 一步法细菌DNA提取纯化试剂盒 50 preps | 50 preps | 3750 |
| AE102 | BcMag™ 一步法细菌DNA提取纯化试剂盒 100 preps | 100 preps | 6750 |
| AF101 | BcMag™ 一步法血液DNA纯化试剂盒 50 preps | 50 preps | 3750 |
| AF102 | BcMag™ 一步法血液DNA纯化试剂盒 100 preps | 100 preps | 6750 |
| AG101 | BcMag™ 一步法口腔细胞DNA提取纯化试剂盒 50 preps | 50 preps | 3750 |
| AG102 | BcMag™ 一步法口腔细胞DNA提取纯化试剂盒 100 preps | 100 preps | 6750 |
| AH101 | BcMag™ 一步法DNA/RNA纯化试剂盒 1ml | 1ml | 2250 |
| AH102 | BcMag™ 一步法DNA/RNA纯化试剂盒 5ml | 5ml | 6750 |
| AI101 | BcMag™ 一步法一代测序纯化试剂盒 1ml | 1ml | 2250 |
| AI102 | BcMag™ 一步法一代测序纯化试剂盒 5ml | 5ml | 6750 |
| AJ101 | BcMag™ One-Step FFPE & FNA DNA提取纯化试剂盒 50 preps | 50 preps | 3750 |
| AJ102 | BcMag™ One-Step FFPE & FNA DNA提取纯化试剂盒 100 preps | 100 preps | 6750 |
| AK101 | BcMag™ 一步法荧光标记物清除试剂盒 1ml | 1ml | 2250 |
| AK102 | BcMag™ 一步法荧光标记物清除试剂盒 5ml | 5ml | 10350 |
| AL101 | BcMag™ 一步法真菌和酵母DNA纯化试剂盒 50 preps | 50 preps | 3750 |
| AL102 | BcMag™ 一步法真菌和酵母DNA纯化试剂盒 100 preps | 100 preps | 6750 |
| AM101 | BcMag™ 一步法昆虫DNA纯化试剂盒 50 preps | 50 preps | 3750 |
| AM102 | BcMag™ 一步法昆虫DNA纯化试剂盒 100 preps | 100 preps | 6750 |
| AN101 | BcMag™ 一步法鼠尾DNA纯化试剂盒 50 preps | 50 preps | 3750 |
| AN102 | BcMag™ 一步法鼠尾DNA纯化试剂盒 100 preps | 100 preps | 6750 |
| AO101 | BcMag™ 一步法NGS纯化试剂盒 1ml | 1ml | 2250 |
| AO102 | BcMag™ 一步法NGS纯化试剂盒 5ml | 5ml | 10350 |
| AP101 | BcMag™ 一步法PCR纯化试剂盒 1ml | 1ml | 2250 |
| AP102 | BcMag™ 一步法PCR纯化试剂盒 5ml | 5ml | 10350 |
| AQ101 | BcMag™ 一步法植物DNA纯化试剂盒 50 preps | 50 preps | 3750 |
| AQ102 | BcMag™ 一步法植物DNA纯化试剂盒 100 preps | 100 preps | 6750 |
| AR101 | BcMag™ 一步法唾液病毒RNA-DNA纯化试剂盒 50 preps | 50 preps | 3750 |
| AR102 | BcMag™ 一步法唾液病毒RNA-DNA纯化试剂盒 100 preps | 100 preps | 6750 |
| AU101 | BcMag™ 一步法RNA清除试剂盒 1ml | 1ml | 2250 |
| AU102 | BcMag™ 一步法RNA清除试剂盒 3ml | 3ml | 5250 |
| AV101 | BcMag™ 一步法DNA/RNA清除试剂盒 1ml | 1ml | 2250 |
| AV102 | BcMag™ 一步法DNA/RNA清除试剂盒 3ml | 3ml | 5250 |
| AW101 | BcMag™ 一步法单链DNA清除试剂盒 1ml | 1ml | 2250 |
| AW102 | BcMag™ 一步法单链DNA清除试剂盒 3ml | 3ml | 5250 |
| AB101 | BcMag™ 骨骼DNA提取纯化试剂盒 50 preps | 50 preps | 3750 |
| AB102 | BcMag™ 骨骼DNA提取纯化试剂盒 100 preps | 100 preps | 6750 |
| AC101 | BcMag™ 游离DNA纯化试剂盒 50 preps | 50 preps | 3750 |
| AC102 | BcMag™ 游离DNA纯化试剂盒 100 preps | 100 preps | 6750 |
| AD101 | BcMag™ 发干DNA纯化试剂盒 50 preps | 50 preps | 3750 |
| AD102 | BcMag™ 发干DNA纯化试剂盒 100 preps | 100 preps | 6750 |
| AF101 | BcMag™ 一步法血液DNA纯化试剂盒 50 preps | 50 preps | 3750 |
| AF102 | BcMag™ 一步法血液DNA纯化试剂盒 100 preps | 100 preps | 6750 |
| AS101 | BcMag™ 一步法脱落细胞DNA纯化试剂盒 50 preps | 50 preps | 3750 |
| AS102 | BcMag™ 一步法脱落细胞DNA纯化试剂盒 100 preps | 100 preps | 6750 |
| AT101 | BcMag™ 精斑DNA纯化试剂盒 50 preps | 50 preps | 3750 |
| AT102 | BcMag™ 精斑DNA纯化试剂盒 100 preps | 100 preps | 6750 |
| AX101 | BcMag™ 一步法PCR抑制剂清除试剂盒 1ml | 1ml | 2250 |
| AX102 | BcMag™ 一步法PCR抑制剂清除试剂盒 5ml | 5ml | 10350 |
| AZ101 | BcMag™ 一步法指纹DNA纯化试剂盒 50 preps | 50 preps | 3750 |
| AZ102 | BcMag™ 一步法指纹DNA纯化试剂盒 100 preps | 100 preps | 6750 |
| AAA101 | BcMag™ 一步法头皮屑DNA纯化试剂盒 50 preps | 50 preps | 3750 |
| AAA102 | BcMag™ 一步法头皮屑DNA纯化试剂盒 100 preps | 100 preps | 6750 |
| MG101 | BcMag™ GST-标签蛋白纯化试剂盒 Kit | Kit | 4425 |
| MG102 | BcMag™ GST-标签蛋白纯化试剂盒 5ml | 5ml | 5925 |
| MG103 | BcMag™ GST-标签蛋白纯化试剂盒 10ml | 10ml | 8250 |
| MHN101 | BcMag™ IDA-Ni His-标签蛋白纯化试剂盒 5ml | 5ml | 5250 |
| MHN102 | BcMag™ IDA-Ni His-标签蛋白纯化试剂盒 10ml | 10ml | 9000 |
| MHN103 | BcMag™ IDA-Ni His-标签蛋白纯化试剂盒 50ml | 50ml | 37500 |
| MHO101 | BcMag™ IDA-Co His-标签蛋白纯化试剂盒 5ml | 5ml | 5250 |
| MHO102 | BcMag™ IDA-Co His-标签蛋白纯化试剂盒 10ml | 10ml | 9000 |
| MHO103 | BcMag™ IDA-Co His-标签蛋白纯化试剂盒 50ml | 50ml | 37500 |
| MHP101 | BcMag™ 分泌型His-标签蛋白纯化试剂盒 5ml | 5ml | 5250 |
| MHP102 | BcMag™ 分泌型His-标签蛋白纯化试剂盒 10ml | 10ml | 9000 |
| MHQ101 | BcMag™ 低表达量His-标签蛋白纯化试剂盒 5ml | 5ml | 5250 |
| MHQ102 | BcMag™ 低表达量His-标签蛋白纯化试剂盒 10ml | 10ml | 9000 |
| HA101 | 2.5µm BcMag™ 链霉亲和素铕荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HA102 | 2.5µm BcMag™ 链霉亲和素铕荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HA103 | 5µm BcMag™ 链霉亲和素铕荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HA104 | 5µm BcMag™ 链霉亲和素铕荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HB101 | 2.5µm BcMag™ 链霉亲和素铽荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HB102 | 2.5µm BcMag™ 链霉亲和素铽荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HB103 | 5µm BcMag™ 链霉亲和素铽荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HB104 | 5µm BcMag™ 链霉亲和素铽荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HC101 | 2.5µm BcMag™ 链霉亲和素钌荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HC102 | 2.5µm BcMag™ 链霉亲和素钌荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HC103 | 5µm BcMag™ 链霉亲和素钌荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HC104 | 5µm BcMag™ 链霉亲和素钌荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HD101 | 2.5µm BcMag™ 单体亲和素铕荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HD102 | 2.5µm BcMag™ 单体亲和素铕荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HD103 | 5µm BcMag™ 单体亲和素铕荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HD104 | 5µm BcMag™ 单体亲和素铕荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HE101 | 2.5µm BcMag™ 单体亲和素铽荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HE102 | 2.5µm BcMag™ 单体亲和素铽荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HE103 | 5µm BcMag™ 单体亲和素铽荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HE104 | 5µm BcMag™ 单体亲和素铽荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HF101 | 2.5µm BcMag™ 单体亲和素钌荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HF102 | 2.5µm BcMag™ 单体亲和素钌荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HF103 | 5µm BcMag™ 单体亲和素钌荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HF104 | 5µm BcMag™ 单体亲和素钌荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HG101 | 2.5µm BcMag™ 蛋白A/G铕荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HG102 | 2.5µm BcMag™ 蛋白A/G铕荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HG103 | 5µm BcMag™ 蛋白A/G铕荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HG104 | 5µm BcMag™ 蛋白A/G铕荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HH101 | 2.5µm BcMag™ 蛋白A/G铽荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HH102 | 2.5µm BcMag™ 蛋白A/G铽荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HH103 | 5µm BcMag™ 蛋白A/G铽荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HH104 | 5µm BcMag™ 蛋白A/G铽荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HI101 | 2.5µm BcMag™ 蛋白A/G钌荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HI102 | 2.5µm BcMag™ 蛋白A/G钌荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HI103 | 5µm BcMag™ 蛋白A/G钌荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HI104 | 5µm BcMag™ 蛋白A/G钌荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HJ101 | 2.5µm BcMag™ 蛋白A铕荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HJ102 | 2.5µm BcMag™ 蛋白A铕荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HJ103 | 5µm BcMag™ 蛋白A铕荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HJ104 | 5µm BcMag™ 蛋白A铕荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HK101 | 2.5µm BcMag™ 蛋白A铽荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HK102 | 2.5µm BcMag™ 蛋白A铽荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HK103 | 5µm BcMag™ 蛋白A铽荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HK104 | 5µm BcMag™ 蛋白A铽荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HL101 | 2.5µm BcMag™ 蛋白A钌荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HL102 | 2.5µm BcMag™ 蛋白A钌荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HL103 | 5µm BcMag™ 蛋白A钌荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HL104 | 5µm BcMag™ 蛋白A钌荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HM101 | 2.5µm BcMag™ 蛋白G铕荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HM102 | 2.5µm BcMag™ 蛋白G铕荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HM103 | 5µm BcMag™ 蛋白G铕荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HM104 | 5µm BcMag™ 蛋白G铕荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HN101 | 2.5µm BcMag™ 蛋白G铽荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HN102 | 2.5µm BcMag™ 蛋白G铽荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HN103 | 5µm BcMag™ 蛋白G铽荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HN104 | 5µm BcMag™ 蛋白G铽荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HO101 | 2.5µm BcMag™ 蛋白G钌荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HO102 | 2.5µm BcMag™ 蛋白G钌荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HO103 | 5µm BcMag™ 蛋白G钌荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HO104 | 5µm BcMag™ 蛋白G钌荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HP101 | 2.5µm BcMag™ 蛋白L铕荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HP102 | 2.5µm BcMag™ 蛋白L铕荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HP103 | 5µm BcMag™ 蛋白L铕荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HP104 | 5µm BcMag™ 蛋白L铕荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HQ101 | 2.5µm BcMag™ 蛋白L铽荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HQ102 | 2.5µm BcMag™ 蛋白L铽荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HQ103 | 5µm BcMag™ 蛋白 L铽荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HQ104 | 5µm BcMag™ 蛋白L铽荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HR101 | 2.5µm BcMag™ 蛋白L钌荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HR102 | 2.5µm BcMag™ 蛋白L钌荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| HR103 | 5µm BcMag™ 蛋白L钌荧光磁珠 0.5ml (10mg/ml) | 0.5ml (10mg/ml) | 3750 |
| HR104 | 5µm BcMag™ 蛋白L钌荧光磁珠 1.5ml (10mg/ml) | 1.5ml (10mg/ml) | 6750 |
| GA101 | 2.5µm BcMag™ 醛基末端铕荧光磁珠 15mg | 15mg | 3750 |
| GA102 | 2.5µm BcMag™ 醛基末端铕荧光磁珠 30mg | 30mg | 6750 |
| GA103 | 5µm BcMag™ 醛基末端铕荧光磁珠 15mg | 15mg | 3750 |
| GA104 | 5µm BcMag™ 醛基末端铕荧光磁珠 30mg | 30mg | 6750 |
| GB101 | 2.5µm BcMag™ 醛基末端铽荧光磁珠 15mg | 15mg | 3750 |
| GB102 | 2.5µm BcMag™ 醛基末端铽荧光磁珠 30mg | 30mg | 6750 |
| GB103 | 5µm BcMag™ 醛基末端铽荧光磁珠 15mg | 15mg | 3750 |
| GB104 | 5µm BcMag™ 醛基末端铽荧光磁珠 30mg | 30mg | 6750 |
| GC101 | 2.5µm BcMag™ 醛基末端钌荧光磁珠 15mg | 15mg | 3750 |
| GC102 | 2.5µm BcMag™ 醛基末端钌荧光磁珠 30mg | 30mg | 6750 |
| GC103 | 5µm BcMag™ 醛基末端钌荧光磁珠 15mg | 15mg | 3750 |
| GC104 | 5µm BcMag™ 醛基末端钌荧光磁珠 30mg | 30mg | 6750 |
| GD101 | 2.5µm BcMag™ 氨基末端铕荧光磁珠 15mg | 15mg | 3750 |
| GD102 | 2.5µm BcMag™ 氨基末端铕荧光磁珠 30mg | 30mg | 6750 |
| GD103 | 5µm BcMag™ 氨基末端铕荧光磁珠 15mg | 15mg | 3750 |
| GD104 | 5µm BcMag™ 氨基末端铕荧光磁珠 30mg | 30mg | 6750 |
| GE101 | 2.5µm BcMag™ 氨基末端铽荧光磁珠 15mg | 15mg | 3750 |
| GE102 | 2.5µm BcMag™ 氨基末端铽荧光磁珠 30mg | 30mg | 6750 |
| GE103 | 5µm BcMag™ 氨基末端铽荧光磁珠 15mg | 15mg | 3750 |
| GE104 | 5µm BcMag™ 氨基末端铽荧光磁珠 30mg | 30mg | 6750 |
| GF101 | 2.5µm BcMag™ 氨基末端钌荧光磁珠 15mg | 15mg | 3750 |
| GF102 | 2.5µm BcMag™ 氨基末端钌荧光磁珠 30mg | 30mg | 6750 |
| GF103 | 5µm BcMag™ 氨基末端钌荧光磁珠 15mg | 15mg | 3750 |
| GF104 | 5µm BcMag™ 氨基末端钌荧光磁珠 30mg | 30mg | 6750 |
| GG101 | 2.5µm BcMag™ 羧基末端铕荧光磁珠 15mg | 15mg | 3750 |
| GG102 | 2.5µm BcMag™ 羧基末端铕荧光磁珠 30mg | 30mg | 6750 |
| GG103 | 5µm BcMag™ 羧基末端铕荧光磁珠 15mg | 15mg | 3750 |
| GG104 | 5µm BcMag™ 羧基末端铕荧光磁珠 30mg | 30mg | 6750 |
| GH101 | 2.5µm BcMag™ 羧基末端铽荧光磁珠 15mg | 15mg | 3750 |
| GH102 | 2.5µm BcMag™ 羧基末端铽荧光磁珠 30mg | 30mg | 6750 |
| GH103 | 5µm BcMag™ 羧基末端铽荧光磁珠 15mg | 15mg | 3750 |
| GH104 | 5µm BcMag™ 羧基末端铽荧光磁珠 30mg | 30mg | 6750 |
| GI101 | 2.5µm BcMag™ 羧基末端钌荧光磁珠 15mg | 15mg | 3750 |
| GI102 | 2.5µm BcMag™ 羧基末端钌荧光磁珠 30mg | 30mg | 6750 |
| GI103 | 5µm BcMag™ 羧基末端钌荧光磁珠 15mg | 15mg | 3750 |
| GI104 | 5µm BcMag™ 羧基末端钌荧光磁珠 30mg | 30mg | 6750 |
| GJ101 | 2.5µm BcMag™ 酰肼基末端铕荧光磁珠 15mg | 15mg | 3750 |
| GJ102 | 2.5µm BcMag™ 酰肼基末端铕荧光磁珠 30mg | 30mg | 6750 |
| GJ103 | 5µm BcMag™ 酰肼基末端铕荧光磁珠 15mg | 15mg | 3750 |
| GJ104 | 5µm BcMag™ 酰肼基末端铕荧光磁珠 30mg | 30mg | 6750 |
| GK101 | 2.5µm BcMag™ 酰肼基末端铽荧光磁珠 15mg | 15mg | 3750 |
| GK102 | 2.5µm BcMag™ 酰肼基末端铽荧光磁珠 30mg | 30mg | 6750 |
| GK103 | 5µm BcMag™ 酰肼基末端铽荧光磁珠 15mg | 15mg | 3750 |
| GK104 | 5µm BcMag™ 酰肼基末端铽荧光磁珠 30mg | 30mg | 6750 |
| GL101 | 2.5µm BcMag™ 酰肼基末端钌荧光磁珠 15mg | 15mg | 3750 |
| GL102 | 2.5µm BcMag™ 酰肼基末端钌荧光磁珠 30mg | 30mg | 6750 |
| GL103 | 5µm BcMag™ 酰肼基末端钌荧光磁珠 15mg | 15mg | 3750 |
| GL104 | 5µm BcMag™ 酰肼基末端钌荧光磁珠 30mg | 30mg | 6750 |
| GM101 | 2.5µm BcMag™ 碘乙酰基末端铕荧光磁珠 15mg | 15mg | 3750 |
| GM102 | 2.5µm BcMag™ 碘乙酰基末端铕荧光磁珠 30mg | 30mg | 6750 |
| GM103 | 5µm BcMag™ 碘乙酰基末端铕荧光磁珠 15mg | 15mg | 3750 |
| GM104 | 5µm BcMag™ 碘乙酰基末端铕荧光磁珠 30mg | 30mg | 6750 |
| GN101 | 2.5µm BcMag™ 碘乙酰基末端铽荧光磁珠 15mg | 15mg | 3750 |
| GN102 | 2.5µm BcMag™ 碘乙酰基末端铽荧光磁珠 30mg | 30mg | 6750 |
| GN103 | 5µm BcMag™ 碘乙酰基末端铽荧光磁珠 15mg | 15mg | 3750 |
| GN104 | 5µm BcMag™ 碘乙酰基末端铽荧光磁珠 30mg | 30mg | 6750 |
| GO101 | 2.5µm BcMag™ 碘乙酰基末端钌荧光磁珠 15mg | 15mg | 3750 |
| GO102 | 2.5µm BcMag™ 碘乙酰基末端钌荧光磁珠 30mg | 30mg | 6750 |
| GO103 | 5µm BcMag™ 碘乙酰基末端钌荧光磁珠 15mg | 15mg | 3750 |
| GO104 | 5µm BcMag™ 碘乙酰基末端钌荧光磁珠 30mg | 30mg | 6750 |
| GP101 | 2.5µm BcMag™ NHS(N-羟基琥珀酰亚胺)末端铕荧光磁珠 15mg | 15mg | 3750 |
| GP102 | 2.5µm BcMag™ NHS(N-羟基琥珀酰亚胺)末端铕荧光磁珠 30mg | 30mg | 6750 |
| GP103 | 5µm BcMag™ NHS(N-羟基琥珀酰亚胺)末端铕荧光磁珠 15mg | 15mg | 3750 |
| GP104 | 5µm BcMag™ NHS(N-羟基琥珀酰亚胺)末端铕荧光磁珠 30mg | 30mg | 6750 |
| GQ101 | 2.5µm BcMag™ NHS(N-羟基琥珀酰亚胺)末端铽荧光磁珠 15mg | 15mg | 3750 |
| GQ102 | 2.5µm BcMag™ NHS(N-羟基琥珀酰亚胺)末端铽荧光磁珠 30mg | 30mg | 6750 |
| GQ103 | 5µm BcMag™ NHS(N-羟基琥珀酰亚胺)末端铽荧光磁珠 15mg | 15mg | 3750 |
| GQ104 | 5µm BcMag™ NHS(N-羟基琥珀酰亚胺)末端铽荧光磁珠 30mg | 30mg | 6750 |
| GR101 | 2.5µm BcMag™ NHS(N-羟基琥珀酰亚胺)末端钌荧光磁珠 15mg | 15mg | 3750 |
| GR102 | 2.5µm BcMag™ NHS(N-羟基琥珀酰亚胺)末端钌荧光磁珠 30mg | 30mg | 6750 |
| GR103 | 5µm BcMag™ NHS(N-羟基琥珀酰亚胺)末端钌荧光磁珠 15mg | 15mg | 3750 |
| GR104 | 5µm BcMag™ NHS(N-羟基琥珀酰亚胺)末端钌荧光磁珠 30mg | 30mg | 6750 |
| MA101 | BcMag™ 蛋白 A/G 纯化试剂盒 Kit | Kit | 5250 |
| MA102 | BcMag™ 蛋白 A/G 磁珠 5ml | 5ml | 5850 |
| MA103 | BcMag™ 蛋白 A/G 磁珠 10ml | 10ml | 9750 |
| MAA101 | BcMag™ 蛋白 A磁珠纯化试剂盒 3ml beads kit | 3ml beads kit | 5250 |
| MAA102 | BcMag™ 蛋白A磁珠 5ml | 5ml | 5850 |
| MAA103 | BcMag™ 蛋白A磁珠 10ml | 10ml | 9750 |
| MAG101 | BcMag™ 蛋白 G磁珠纯化试剂盒 3ml beads kit | 3ml beads kit | 5250 |
| MAG102 | BcMag™ 蛋白G磁珠 5ml | 5ml | 5850 |
| MAG103 | BcMag™ 蛋白G磁珠 10ml | 10ml | 9750 |
| MAL101 | BcMag™ 蛋白 L磁珠纯化试剂盒 3ml beads kit | 3ml beads kit | 5250 |
| MAL102 | BcMag™ 蛋白L磁珠 5ml | 5ml | 5850 |
| MAL103 | BcMag™ 蛋白L磁珠 10ml | 10ml | 9750 |
| EA101 | BcMag™ 快速抗体纯化试剂盒 2ml | 2ml | 2250 |
| EA102 | BcMag™ 快速抗体纯化试剂盒 10ml | 10ml | 8250 |
| EB101 | BcMag™ 一步法抗体纯化试剂盒 2ml | 2ml | 2250 |
| EB102 | BcMag™ 一步法抗体纯化试剂盒 10ml | 10ml | 8250 |
| EC101 | BcMag™ 硼酸亲和磁珠磁珠 250mg | 250mg | 5175 |
| EC102 | BcMag™ 硼酸亲和磁珠磁珠 500mg | 500mg | 9750 |
| MMI101 | BcMag™ 单体亲和素磁珠 Kit | Kit | 7275 |
| MMI102 | BcMag™ 单体亲和素磁珠 5ml | 5ml | 8250 |
| MMI103 | BcMag™ 单体亲和素磁珠 10ml | 10ml | 14250 |
| MMI105 | BcMag™ 链酶亲和素磁珠 5ml | 5ml | 5250 |
| MMI106 | BcMag™ 链酶亲和素磁珠 10ml | 10ml | 9750 |
| MMI107 | BcMag™ 可洗脱式链酶亲和素磁珠 2ml | 2ml | 3750 |
| MMI108 | BcMag™ 可洗脱式链酶亲和素磁珠 5ml | 5ml | 8250 |
| MMI109 | BcMag™ 可洗脱式链酶亲和素磁珠 10ml | 10ml | 13500 |
| FM101 | 1µm BcMag™ DEAE 磁珠 250mg | 250mg | 5175 |
| FM102 | 1µm BcMag™ DEAE 磁珠 500mg | 500mg | 9750 |
| FM103 | 5µm BcMag™ DEAE 磁珠 250mg | 250mg | 5175 |
| FM104 | 5µm BcMag™ DEAE 磁珠 500mg | 500mg | 9750 |
| FM105 | 1µm BcMag™ PSA 磁珠 250mg | 250mg | 5175 |
| FM106 | 1µm BcMag™ PSA 磁珠 500mg | 500mg | 9750 |
| FM107 | 5µm BcMag™ PSA 磁珠 250mg | 250mg | 5175 |
| FM108 | 5µm BcMag™ PSA磁珠 500mg | 500mg | 9750 |
| FN101 | 1µm BcMag™ WCX 磁珠 250mg | 250mg | 5175 |
| FN102 | 1µm BcMag™ WCX 磁珠 500mg | 500mg | 9750 |
| FN103 | 5µm BcMag™ WCX 磁珠 250mg | 250mg | 5175 |
| FN104 | 5µm BcMag™ WCX 磁珠 500mg | 500mg | 9750 |
| FU101 | 1µm BcMag™ SAX 磁珠 250mg | 250mg | 5175 |
| FU102 | 1µm BcMag™ SAX 磁珠 500mg | 500mg | 9750 |
| FU103 | 5µm BcMag™ SAX 磁珠 250mg | 250mg | 5175 |
| FU104 | 5µm BcMag™ SAX 磁珠 500mg | 500mg | 9750 |
| FV101 | 1µm BcMag™ SCX 磁珠 250mg | 250mg | 5175 |
| FV102 | 1µm BcMag™ SCX 磁珠 500mg | 500mg | 9750 |
| FV103 | 5µm BcMag™ SCX 磁珠 250mg | 250mg | 5175 |
| FV104 | 5µm BcMag™ SCX 磁珠 500mg | 500mg | 9750 |
| DA101 | 1µm BcMag™ PEI 磁珠 250mg | 250mg | 5175 |
| DA102 | 1µm BcMag™ PEI 磁珠 500mg | 500mg | 9750 |
| DA103 | 5µm BcMag™ PEI磁珠 250mg | 250mg | 5175 |
| DA104 | 5µm BcMag™ PEI 磁珠 500mg | 500mg | 9750 |
| FO101 | 1µm BcMag™ 羟基磷灰石磁珠 250mg | 250mg | 5175 |
| FO102 | 1µm BcMag™ 羟基磷灰石磁珠 500mg | 500mg | 9750 |
| FK101 | 1µm BcMag™ C-8 磁珠 250mg | 250mg | 5175 |
| FK102 | 1µm BcMag™ C-8 磁珠 500mg | 500mg | 9750 |
| FK103 | 5µm BcMag™ C-8 磁珠 250mg | 250mg | 5175 |
| FK104 | 5µm BcMag™ C-8 磁珠 500mg | 500mg | 9750 |
| FL101 | 1µm BcMag™ C-18 磁珠 250mg | 250mg | 5175 |
| FL102 | 1µm BcMag™ C-18 磁珠 500mg | 500mg | 9750 |
| FL103 | 5µm BcMag™ C-18 磁珠 250mg | 250mg | 5175 |
| FL104 | 5µm BcMag™ C-18 磁珠 500mg | 500mg | 9750 |
| FS101 | 1µm BcMag™ C-4 磁珠 250mg | 250mg | 5175 |
| FS102 | 1µm BcMag™ C-4 磁珠 500mg | 500mg | 9750 |
| FS103 | 5µm BcMag™ C-4 磁珠 250mg | 250mg | 5175 |
| FS104 | 5µm BcMag™ C-4 磁珠 500mg | 500mg | 9750 |
| FS105 | 1µm BcMag™ 氰基丙基磁珠 250mg | 250mg | 5175 |
| FS106 | 1µm BcMag™ 氰基丙基磁珠 500mg | 500mg | 9750 |
| FS107 | 5µm BcMag™ 氰基丙基磁珠 250mg | 250mg | 5175 |
| FS108 | 5µm BcMag™ 氰基丙基磁珠 500mg | 500mg | 9750 |
| FT101 | 1µm BcMag™ 苯环基磁珠 250mg | 250mg | 5175 |
| FT102 | 1µm BcMag™ 苯环基磁珠 500mg | 500mg | 9750 |
| FT103 | 5µm BcMag™ 苯环基磁珠 250mg | 250mg | 5175 |
| FT104 | 5µm BcMag™ 苯环基磁珠 500mg | 500mg | 9750 |
| FT105 | 1µm BcMag™ 二苯基磁珠 250mg | 250mg | 5175 |
| FT106 | 1µm BcMag™ 二苯基磁珠 500mg | 500mg | 9750 |
| FT107 | 5µm BcMag™ 二苯基磁珠 250mg | 250mg | 5175 |
| FT108 | 5µm BcMag™ 二苯基磁珠 500mg | 500mg | 9750 |
| AY101 | BcMag™ 高纯度质粒提取试剂盒 5ml | 5ml | 4125 |
| AY102 | BcMag™ 高纯度质粒提取试剂盒 10ml | 10ml | 7875 |
| CA101 | BcMag™ 快速 Oligo-DNA偶联试剂盒 100mg Beads Kit | 100mg Beads Kit | 5400 |
| CA102 | BcMag™ 快速 Oligo-DNA偶联试剂盒 200mg Beads Kit | 200mg Beads Kit | 9750 |
| CA103 | BcMag™ RNA-DNA偶联试剂盒 100mg Beads Kit | 100mg Beads Kit | 5400 |
| CA104 | BcMag™ RNA-DNA偶联试剂盒 200mg Beads Kit | 200mg Beads Kit | 9750 |
| MMS101 | BcMag™ 快速mRNA提取纯化试剂盒 Kit | Kit | 4800 |
| MMS102 | BcMag™ Oligo-dT 磁珠 4ml | 4ml | 5700 |
| BA101 | BcMag™ 一步法脂质清除试剂盒 1ml | 1ml | 2250 |
| BA102 | BcMag™ 一步法脂质清除试剂盒 5ml | 5ml | 10350 |
| BB101 | BcMag™ 一步法脱蛋白清除试剂盒 1ml | 1ml | 2250 |
| BB102 | BcMag™ 一步法脱蛋白清除试剂盒 5ml | 5ml | 10350 |
| BC101 | BcMag™ 一步法SDS清除试剂盒 1ml | 1ml | 2250 |
| BC102 | BcMag™ 一步法SDS清除试剂盒 5ml | 5ml | 10350 |
| BD101 | BcMag™ 一步法去垢剂清除试剂盒 1ml | 1ml | 2250 |
| BD102 | BcMag™ 一步法去垢剂清除试剂盒 5ml | 5ml | 10350 |
| BE101 | BcMag™ 快速白蛋白清除试剂盒 25x preps Kit | 25x preps Kit | 3750 |
| BE102 | BcMag™ 快速白蛋白清除试剂盒 2.5ml beads, 100x preps | 2.5ml beads, 100x preps | 9750 |
| BF101 | BcMag™ 快速 HSA-IgG清除试剂盒 25x preps Kit | 25x preps Kit | 3750 |
| BF102 | BcMag™ 快速 HSA-IgG清除试剂盒 2.5ml beads, 100x preps | 2.5ml beads, 100x preps | 9750 |
| BG101 | BcMag™ 一步法染料清除试剂盒 1ml | 1ml | 2250 |
| BG102 | BcMag™ 一步法染料清除试剂盒 5ml | 5ml | 10350 |
| BH101 | BcMag™ 固定化TCEP二硫化物还原试剂盒 100mg | 100mg | 3750 |
| BH102 | BcMag™ 固定化TCEP二硫化物还原试剂盒 500mg | 500mg | 6750 |
| MKE101 | BcMag™ 快速内毒素清除试剂盒 Kit | Kit | 5250 |
| MKE102 | BcMag™ 快速内毒素清除试剂盒 5ml Beads | 5ml Beads | 7425 |
| MKE103 | BcMag™ 快速内毒素清除试剂盒 20ml of 10x regeneration buffers | 20ml of 10x regeneration buffers | 2535 |
| FQ101 | BcMag™ EDTA金属离子清除试剂盒 150mg | 150mg | 4125 |
| FQ102 | BcMag™ EDTA金属离子清除试剂盒 300mg | 300mg | 7875 |
| BI101 | BcMag™ EGTA金属离子清除试剂盒 150mg | 150mg | 4125 |
| BI102 | BcMag™ EGTA金属离子清除试剂盒 300mg | 300mg | 7875 |

美国Plant Cell Technology公司为商业及研究用植物组织培养实验室和植物种植者开发、生产了旗舰产品PPM™ (Plant Preservative Mixture),它是一种广谱抗微生物剂,可以杀死细菌和真菌细胞,防止真菌孢子的萌发,并在较高浓度下能消除内源性污染的外植体。研究表明PPM™活性成分可以渗透过真菌或细菌细胞壁,抑制柠檬酸循环和电子传递链等中心代谢循环中的关键酶的活性,并且可以抑制培养基中的单糖和氨基酸向真菌和细菌细胞的运输。PPM™能有效地抑制植物细胞和植物组织培养中的通过空气、水、人传播的微生物污染及内源性污染,而不会影响体外种子发芽、愈伤组织增殖和愈伤组织的再生。并且,PPM™具有热稳定性,可以和培养基一起灭菌,同时比常用抗生素价更低廉,可以作为植物组织培养基的标准成分。
The principal PCT scientist involved in the development of the PPM™ application is Dr. Assaf Guri. Dr. Assaf Guri holds degrees in genetics, applied genetics and plant breeding from the Hebrew University in Jerusalem and Michigan State University in the US. Before joining Plant Cell Technology, Inc., Dr. Guri worked with the Volcani Agricultural Research Center in Israel, Michigan State University in East Lansing, Michigan and DNAP in New Jersey.
<更多详情请联系
艾美捷科技有限公司
全国服务热线:400-6800-868
邮箱:sales@amyjet.com
网站:www.amyjet.com

艾美捷科技代理Tatua大拓品牌。
▌公司介绍
大拓位于新西兰畜牧中心地带,是新西兰历史最悠久的乳制品公司,创立于1914年。大拓研发生产专业蛋白胨,用于诊断培养基、发酵培养基、益生菌、生物制药和细胞培养行业,其蛋白胨都符合清真和犹太洁食标准。

更多详情请咨询→

全国免费热线:400-6800-868
直拨专线:+86-027-59626688;18771997407
客服QQ一:17754422825;
客服QQ二:18771149750
▌产品系列
大拓能够提供多样化的蛋白胨组合,以适应全球发酵和益生菌培养基细分市场的一系列应用需求。我司代理的产品类别包括乳糖蛋白胨及植物蛋白胨。
| 乳糖蛋白胨 |
大拓 (Tatua) 提供一系列源自新西兰、无BSE/TSE风险的纯净奶源的乳蛋白胨产品。
● 酪蛋白胨(清真胰蛋白胨):其化学组成、成分和物理特性均经过精心设计,以匹配更传统的胰蛋白酶消化酪蛋白(胰蛋白胨)产品的规格。
● 乳清蛋白胨(乳白蛋白酶解物):能够支持苛养菌的生长,常用于需要特定氨基酸谱的益生菌应用领域。
大拓 (Tatua) 的乳蛋白胨产品组合涵盖广泛的优势,包括:
● 过滤级产品:提供澄清度与热稳定性
● 非过滤级产品:更具成本效益
● 清真 (Halal) 与洁食 (Kosher) 认证
● 多种游离氨基酸谱 (FAA profiles):以支持最佳生长性能
| Product | Protein Source | Filtered | pH | Total Nitrogen | Amino Nitrogen | AN/TN | Ash | Features / Benefits |
| EHCK | Casein | No | 6.6 | 13.80% | 5.50% | 39.90% | 3.50% | ● Cost effective nitrogen source |
| HCP275 | Casein | Yes | 6.9 | 13.60% | 4.30% | 31.80% | 5.50% | ● Halal alternative to tryptone ● Meets pancreatic digest of casein USP criteria |
| HCP321 | Casein | Yes | 6.8 | 13.60% | 5.80% | 42.50% | 4.50% | ● Halal alternative to tryptone ● Good source of free amino acids |
| HCP512 | Casein | Yes | 6.8 | 14.30% | 2.60% | 18.20% | 4.00% | ● Specially designed for use in biopharma fermentations |
| Tatua 2400 | Casein | Yes | 6.9 | 13.40% | 4.40% | 32.90% | 5.80% | ● Supports growth of fastidious bacteria ● Halal alternative to tryptone |
| Tatua 2016 | Whey | Yes | 6.4 | 12.20% | 4.90% | 40.40% | 4.50% | ● Supports growth of fastidious bacteria |
| 植物蛋白胨 |
大拓 (Tatua)将酶解技术和下游加工技术应用于非乳制品蛋白原料,提供无动物成分和/或无过敏原特性的蛋白胨解决方案,作为传统(动物源)蛋白胨的替代品。
● Tatua大豆蛋白胨:是某些诊断培养基配方(如 TSA 和 TSB)的重要组成部分,并且在益生菌发酵应用中表现成熟可靠。
● Tatua豌豆蛋白胨:旨在解决大豆蛋白胨可能引起的大豆过敏原问题而开发,适用于益生菌应用。
<| Product | Protein Source | Filtered | pH | Total Nitrogen | Amino Nitrogen | AN/TN | Ash | Features / Benefits |
| HSP320 | Soy | Yes | 6.9 | 9.20% | 2.50% | 26.90% | 7.10% | ● Good source of free amino acids |
| HSP348 | Soy | No | 7 | 9.10% | 1.70% | 18.60% | 7.80% | ● Cost effective nitrogen and carbohydrate source |
| HSP349 | Soy | Yes | 7 | 9.60% | 1.80% | 19.00% | 7.40% | ● Meets papaic digest of soy USP criteria |
| HSP429 | Soy | Yes | 7.1 | 9.80% | 2.70% | 27.00% | 8.80% | ● Supports growth of fastidious bacteria ● Stable in buffered solutions |
| Tatua 5260 | Pea | Yes | 6.4 | 13.60% | 4.40% | 32.30% | 4.80% | ● Good source of free amino acids ● Dairy-free ● Soy-free |
▌产品优势
大拓微生物营养解决方案具有以下优势:
● 大拓用于生产蛋白胨的乳蛋白原料(酪蛋白和乳清蛋白)都是直接来源于新西兰自有农场的奶源,是唯一一家能够全方位供应乳蛋白原料的蛋白胨生产商
● 新西兰来源的乳蛋白原料符合无BSE/TSE要求
● 植物蛋白为非转基因来源
● 大批量生产(高达8MT)降低单位成本
● FSSC 22000-Q 认证确保满足最高水平的质量要求
● 专业的研发团队能够根据不同培养基的需求提供定制化解决方案
● 出厂保质期为60个月
▌大拓蛋白胨的促生长性能




Toronto Research Chemical建立于1982年,致力于为生物医药研发人员提供小分子有机物,库存超过57000种,并通过一系列方法保证标准物质的纯度。
Toronto Research Chemicals, TRC, was founded in 1982 by Dr. David Dime to manufacture and supply researchers in the biomedical fields with specialized complex organic small molecules that were not commercially available. In 1983, the company was incorporated in Ontario as Toronto Research Chemicals Inc. It was initially located at the University of Toronto. As the business expanded, larger facilities were required to accommodate the growth.
Today, Toronto Research Chemicals Inc. employs about 150 full time staff, of which approximately 80 are PHD's, operating in a 65,000 square foot facility. TRC, currently manufactures and distributes in excess of 33,000 products to more than 65 countries.
Toronto Research Chemical的产品涵盖:
Activators; Affinity Chromatography; Agonists; Agro-Products; Aldehyde Labeling Reagents; Aldehydes; Amines; Amino Acids & Derivatives; Anti-virals; Antibiotics; Apoptosis; Benzodiazepines; Biotin Derivatives; Boron Derivatives; Carbohydrates; Catalysts; Charged Bifunctional Reagents; Charged Monofunctional Reagents; Chelating Agents & Ligands; Chiral Reagents; Chromatography Media; Cross Linking Reagents; Crosslinker; CyanineDyes; Detergents; Diagnostics; Dihydropyridine; Dopamines; DrugAnalogues; ElectrophoresisMaterials; Environmental; Enzyme Substrates; Ephedrines; Fatty Acids & Derivatives; Fentanyls; Fluorescent Labels &Indicators; Glucuronides; Glutathione S-Transferase Agents; Glycerols; Glycosidase Inhibitors; Heterocycles; Hydantoins; Impurities; Indole Derivatives; Inhibitors; Inositols; Isotope Labelled Compounds; Labeling and Diagnostics Reagents; Lipids; Lysergic Acid and Derivatives; Maleimide Derivatives; Mercaptans/Thiols; Metabolites; Methadones and Analogues; Miscellaneous Compounds; Morphine Based Alkaloids; MTS & Sulfhydryl Active Compounds; Mutagenesis Research Chemicals; Neurochemicals; Neutral Bifunctional Reagents; Neutral Monofunctional Reagents; Nicotine Derivatives; Nitric Oxide Reagents; Non-nucleoside Reverse Transcriptase; Nucleotides; Oligosaccharides; Opium Alkaloids - Natural and Derivatives; Peptides; Pharmaceuticals; Phenethylamines; Phosphorylating and Phosphitylating Agents; Phosphorylcholine Derivatives; Photoaffinity Labels; Polyethyleneglycol Derivatives; Polymers; Protein Kinase Inhibitors and Activators; Pyridyl Disulfides; Retinoids; Selenium Compounds; Sphingosine Derivatives; Spin Labeling Compounds; Steroids; Sulfonyl Chlorides; Tyrosine Kinase Inhibitors; Wittig Reagents.
<更多详情请联系
艾美捷科技有限公司
全国服务热线:400-6800-868
邮箱:sales@amyjet.com
网站:www.amyjet.com
" data-original="http://pharna.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Toronto Research Chemicals"> Toronto Research Chemicals地址:武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301
电话:17754422825
传真:18372041646
邮箱:sales@amyjet.com
0.3202